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ABSTRACT 
The ALS Genes TDP-43 AND FUS/TLS Regulate a Common Pathway in the 
Nervous System of Drosophila melanogaster  
Jonathan!R.!Brent!
 
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder 
characterized by the dysfunction and death of motor neurons. Patients afflicted 
with this condition commonly experiences muscle weakness that progresses to 
generalized paralysis. Although most ALS cases are sporadic, mutations in 
several human genes of divergent molecular function have been linked to the 
development of ALS. Recently, two new ALS genes, TDP-43 and FUS, were 
identified that have structural similarities suggesting that they may function in a 
common process. TDP-43 and FUS have both been implicated in a number of 
cellular functions, including the regulation of splicing, transcription, and 
microRNA processing. The work in this thesis includes studies that identified 
roles for TDP-43 and FUS in the health and function of the nervous system of 
Drosophila melanogaster. Genetic and biochemical studies were used to define 
the molecular relationships between TDP-43 and FUS, placing TDP-43 upstream 
of FUS in a common pathway that is important for the function and health of the 
nervous system. The finding that TDP-43 and FUS interact suggests that they 
regulate a common disease pathway that is disrupted in ALS and that therapeutic 
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Chapter 1 Introduction 
1.1 Amyotrophic Lateral Sclerosis 
1.1.1  Historical Perspective 
 During the nineteenth century, which many regard as the age of the 
genesis of modern neuroscience, knowledge regarding neurological disease 
grew at a staggering rate.  Scholars during the previous centuries made large 
advancements in the understanding of normal brain anatomy. However, they 
could still only guess at the functions of specific regions of the nervous system. It 
was during this time that Franz Joseph Gall’s Phrenology was popular thought.  
An understanding of neural disease truly started when anatomists began to look 
at brain specimens from their patients and discovered lesions resulting in the 
introduction of a fundamental shift in thinking, i.e. that neurological disease is 
caused by lesions within the nervous system. Thus, one could attempt to 
understand normal brain function by correlating abnormal anatomical or 
pathological findings with clinical symptoms.  
The work of Matthew Baillie pointed the way. In his 1793 book, The Morbid 
Anatomy of the Most Important Parts of the Human Body, he was likely the first 
to describe pathological specimens of diseased brains (Baillie, 1808). Most 
notable were the findings that patients who survived a massive stroke often 
displayed hemiplegia and that the stroke lesions almost always occurred on the 
opposite side of the brain. Thus, he reasoned correctly that the motor control of 
each side of the body resides in the opposite side of the brain. It is not surprising 
then that the neurologists of the nineteenth century and those that followed spent 
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their days cataloging the symptoms of their patients, trying to group them based 
on those symptoms, and comparing those notes with their patient’s post-mortem 
specimens. It was during this time that world saw the description of Bell’s Palsy 
(1811) and James Parkinson’s An Essay on the Shaking Palsy was published 
(1817). Later, support grew for the localization of cortical functions when 
Wernicke and Broca discovered their respective areas controlling the 
coordination of language.  
In addition to describing facial nerve palsy, Charles Bell was the first to 
describe the distinction between the sensory and motor functions within the 
nervous system. Notably, his accounts in 1836 and later those of Aran and 
Cruveilhier are believed to be the first of lower motor neuron disease. Later in the 
1860s classical cases of combined upper and lower motor neuron disease were 
reported in the papers of Lockhart Clarke and Charles Radcliffe (Turner et al., 
2010). Nevertheless, the origin of the name for this combined motor neuron 
disease lies with Jean-Martin Charcot who in 1874 coined the term Amyotrophic 
Lateral Sclerosis (ALS) (Rowland, 2001).  
The nineteenth century was a very important time in neuroscience 
because many of the diseases and ideas that originated during this period are 
still subjects of major study. It can undoubtedly be said that these great scholars 
of the past laid a foundation upon which the scientific community is still building. 
The work of Charcot and others successfully characterized ALS as a rapidly 
progressive fatal disease caused by the death and disease of motor neurons. 
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Unfortunately, during the 140 years since the discovery of ALS and the many 
other neurological diseases described during this period, our understanding of 
these diseases has grown slowly and few if any effective therapies exist. 
1.1.2  Pathological Features 
The term Amyotrophic Lateral Sclerosis is derived from the 
clinical/pathological features of the disease. Amyotrophic stems from the muscle 
wasting that occurs as input from the motor neurons is lost. Lateral sclerosis 
describes the fibrotic changes that occur in the lateral corticospinal descending 
tract of the spinal cord.  An important pathological feature of the disease is the 
loss of motor neurons that occurs in the anterior horns of the spinal cord and 
often in the premotor cortex.  Inside the remaining cells, cytoplasmic inclusions 
and accumulations are often present. These take numerous different forms 
including neurofilament inclusions, ubiquitinated inclusions, Bunina bodies, 
Basophilic inclusions, and Hyaline inclusions (Talbot, 2009). Wallerian 
degeneration occurs and is visible in brain biopsy as atrophy and pallor of 
myelinated motor axons in the corticospinal tracts (Di Trapani et al., 1986). 
Additional findings in the corticospinal tracts include numerous axonal swellings 
containing neurofilament inclusions (Okamoto et al., 1990). 
1.1.3  Symptoms and Diagnosis 
 The most common symptom of ALS is muscle weakness, which occurs 
most often in a single limb (Rowland, 1998; Sathasivam, 2010). Alternatively, 
patients can present with difficulty swallowing or speaking and at a much lower 
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rate the initial symptoms arise in the muscles of the trunk, which can affect 
breathing. Nevertheless, as time progresses, weakness increases and begins to 
spread to other areas of the body. However, the initial symptoms can sometimes 
be much more general and insidious such as weight loss or changes in 
emotionality or cognitive functioning. Commonly patients may attribute localized 
muscle weakness to overuse injuries and present to the physician only once they 
notice that symptoms have progressed. 
 The diagnosis of ALS is based on clinical criteria, as no definitive tests 
exist. Thus, the physician must evaluate patients based on clinical presentation. 
This task is complicated by the fact the initial site of dysfunction can vary based 
on the degree to which either upper motor neuron (UMN) vs. lower motor neuron 
(LMN) involvement predominates. The EL Escorial clinical criterion was 
developed in 1994 and since that time has been the standard for the evaluation 
of patients suspected of ALS (Brooks, 1994; Wilbourn, 1998; Brooks et al., 2000).  
The standard requires the presence of UMN and LMN symptoms that have 
spread over time without the presence of electrophysiological, pathological, or 
radiological findings that could be explained by other disease processes. 
Commonly patients present with symptoms that meet some but not all of these 
criteria and the neurologist must delay diagnosis to wait for symptoms to evolve. 
Thus, the median time to diagnosis is 14 months and patients are often 
misdiagnosed (Chiò, 1999; Chieia et al., 2010).  
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1.1.3  Epidemiology  
ALS is the most common form of motor neuron disease, and it affects 
individuals from every ethnicity and race (Bobowick, 1973). The incidence of ALS 
in the US is two cases per 100,000 people per year (Beghi et al., 2006). The 
prevalence is nearly seven cases per 100,000 people. Thus, in the US between 
20,000 and 30,000 people have ALS, with an estimated 5,000 people diagnosed 
each year. Men are slightly more at risk for the disease with a lifetime risk of 1 in 
350 versus a risk of 1 in 420 for women (Armon, 2007; McCombe and 
Henderson, 2010) . Though juvenile forms of the disease exist, the mean age of 
onset ranges between 55 and 65 years of age (Kiernan et al., 2011). While some 
patients with atypical disease can live longer, the majority of patients with ALS 
die within 5 years. Patients with symptoms of dysfunction in the muscles of trunk 
or oropharynx at diagnosis have a more rapid course of disease (Talbot, 2009). 
1.1.4  Environmental Risk Factors  
There have been many hypotheses for the cause of ALS, and evidence 
supports the idea that both environmental and genetic factors can contribute to 
risk of disease. About 5-10 % of ALS is caused by familial disease, and the 
remaining 90% is sporadic. Neurotoxins have been shown to cause ALS. One 
such neurotoxin, the β-methyl-amino-L-alanine (BMAA) was shown to be 
responsible for the epidemic of ALS-Parkinson’s disease within the Chamorro 
people of Guam (Jonasson et al., 2010). Other environmental factors that have 
been associated with increased risk of ALS in construction workers include paint 
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strippers, pesticides, lead, antifreeze, dry cleaning agents, and other chemicals 
present in the workplace (Qureshi et al., 2006; 2006; Okamoto et al., 2009; Fang 
et al., 2009). Lifestyle factors such as increased physical activity, poor diet, and 
smoking have also been associated with increased risk (Okamoto et al., 2009; 
Weisskopf et al., 2010). Additionally, one Swedish study found that maternal age 
of under 20 and greater than 40 confers increased risk of ALS (Fang et al., 
2008).  
1.1.5 Genetic Risk Factors 
Table 1 Genes associated with the development of ALS 
Gene 
Name 
Locus Year  Lesion Onset Function Inheritance 





ANG 14q11.2 2006 Missense  Adult Ribonuclease Dominant 
ATX2 12q24.12 2010 Trinucleotide 
Expansion 
Adult RNA Metabolism Dominant 
C9ORF72 9p21 2011 Hexanucleotide 
Expansion 
Adult Unknown Dominant 
DCTN1 2p13 2004 Missense  Adult Cellular Trafficking Dominant 
ELP3 8p21.1 2008 Missense  Adult RNA Metabolism Dominant 
FIG4 6q21 2009 Missense  Adult PIP Phosphatase Dominant 
FUS/TLS 16p11.2 2009 Missense, Nonsense, 
& Deletion  
Adult RNA Metabolism Recessive  
Dominant 





2010 Missense, Nonsense,  
& Deletion 
Adult Innate Immunity Recessive 
Dominant 
SETX 9q34.13 2004 Missense Mutation Juvenile DNA/RNA Helicase Dominant 
SOD1 21q22.1 1993 Missense & Nonsense  Adult Oxidative Stress Dominant  
SPG11 15q14 2010 Missense Juvenile Unknown Recessive 
TDP-43 1p36.2 2008 Missense & Nonsense  Adult RNA Metabolism Dominant 
UBQLN2 Xp11.21 2011 Missense  Adult Protein Degradation Dominant 
VAPB 20q13.3 2004 Missense Adult Vesicle Trafficking Dominant 
VCP 9p13.3 2010 Missense Adult Protein Degradation Dominant 
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Much effort has been given to the identification of the genetic factors 
associated with ALS. These efforts have been greatly helped by mapping studies 
carried out in ALS families. The first ALS gene, Super Oxide Dismutase 1 
(SOD1), was identified in 1993 when 11 different SOD1 mutations were 
discovered in 13 different FALS families (Rosen et al., 1993). SOD1 mutations 
are responsible for ~20% of familial ALS and ~1% of sporadic cases.  Recently, 
there has been an acceleration in the discovery of genes associated with familial 
ALS, with 16 known genes in total (Kiernan et al., 2011; 2011; Renton et al., 
2011). Further study has shown that in many cases these genes are involved in 
sporadic ALS as well. 
1.1.5  Pathogenesis 
The recent success in the discovery of ALS genes has added more insight 
and also more complexity to the putative mechanism of ALS, which in spite of 
many years of research still remains elusive. The putative functions of these 
genes are wide ranging, but some commonalities exist. Several classes of genes 
have emerged including those involved in RNA metabolism, protein degradation, 
and vesicle trafficking.  Many of the genes are multifunctional and the hurdle at 
this point is identifying which of the functions are related to the pathogenesis of 
ALS.  Additionally, the pathogenic mechanisms of the individual genes may be 
complex, with some mutations in the same gene causing different effects on 
function. In some cases, gain-of-function and dominant-negative mechanisms 
have been proposed.  
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 Explanations regarding the key sources of pathogenesis in ALS can be 
grouped into several main categories. The first category centers on dysfunction 
that begins in the UMN, which in turn alters signaling to the LMN resulting in its 
death.  In this mechanism, deemed the “dying forward” mechanism, excess 
Glutamate neurotransmitter is released onto the postsynaptic neuron causing 
activation of calcium dependent alterations in cell function. Key evidence to 
support this mechanism comes from the finding that cortical hyperexcitability 
precedes the clinical onset of familial ALS and appears very early in sporadic 
ALS. The motor neurons without monosynaptic connection with 
corticomotoneurons are also typically spared in ALS.  These findings have been 
supported in studies that have detected elevated Glutamate in the CSF of 
patients and also SOD1 mouse models. Additionally, the only FDA approved 
drug for ALS, Riluzole, is an antiglutamatergic agent (Miller et al., 2007). 
Nevertheless, since this drug only has a modest effect on survival, it is likely that 
glutamate toxicity is only one of several processes ongoing in ALS pathology.  
The second category of ALS pathogenic mechanisms centers on the idea 
that signaling from the muscle cell through the neuromuscular junction is altered 
and that this causes neuronal dysfunction to progress upwards in a “dying 
backward” mechanism (Dadon-Nachum et al., 2011). One of the key reasons 
why this idea has taken hold is the finding that synaptic denervation often occurs 
prior to observable motor neuron degeneration (Frey et al., 2000).  In SOD1 
mouse models it was found that in the early stages of disease, the serine 
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threonine kinase, Cdk5, is down regulated.  Cdk5 is implicated in important 
aspects of muscle function like acetylcholine receptor clustering and myogeneis 
(Park and Vincent, 2008). Thus, it seems that muscle dysfunction is an early 
event in ALS, preceding symptoms and denervation. In some cases, repulsive 
factors such as Semaphorin 3A and Nogo-A are aberrantly expressed by the 
muscle causing denervation (Jokic et al., 2005; De Winter et al., 2006). In other 
cases it seems that the opposite is true and that survival signals from the muscle 
such as glial cell-line derived neurotrophic factor (GDNF) and insulin growth 
factor are lost (Dadon-Nachum et al., 2011).  
The retrograde signaling pathways require transport of those signals to the 
cell body. Specifically, signaling by the transforming growth factor TGF-β 
pathway, which is important for neuromuscular junction (NMJ) development, is 
downregulated in the motorneurons of ALS patient autopsy specimens 
(Nakamura et al., 2008). Several ALS genes that might be involved in the 
process of retrograde synaptic signaling processes include: Alsin (ALS2), which 
is important for endosome formation; Dynactin 1 (DNCT1), which plays a role in 
the retrograde transport of endosomal cargos; and vesicle associated membrane 
protein (VAMP)/synaptobrevin-associated membrane protein B (VAPB), which is 
involved in vesicle trafficking (Yang et al., 2001; Münch et al., 2004; Nishimura et 
al., 2004; Ratnaparkhi et al., 2008). Mutations in Dynactin and VAPB Drosophila 
homologs p150/Glued and VAP-33A have been shown to interfere with TGF-β 
signaling at the NMJ.  
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 An alternate mechanism for dysfunction caused by deficient retrograde as 
well as anterograde trafficking mechanisms is evident in the pathological axonal 
swellings found in ALS (Okamoto et al., 1990). These contain accumulations 
composed of neurofilaments and also what appear to be damaged organelles. In 
ALS mouse models, defective axonal transport has been demonstrated in vivo 
(Bilsland et al., 2010). This could cause not only the disruption of signaling 
between the cell body and synapse, but also the disruption of mitochondrial 
recycling and a synaptic energy deficit (Magrané and Manfredi, 2009).  
In an effort to understand the “dying back” mechanism in ALS some have 
hypothesized that the processes of synaptic and axonal remodeling/regeneration 
are important throughout life. It has been found that mutation in Angiogenin 
(ANG), which is responsible for 1% of ALS, leads to impaired neurite extension 
and pathfinding (Subramanian et al., 2008). Thus, it is possible that in ALS, ANG 
mutations disrupt the process of reinnervation in response to injury and over time 
lead to a gradual loss of motor neurons. The vital role for reinnervation was 
demonstrated by several studies that found improved survival in ALS mouse 
models in response to enhanced reinnervation alone. Muscle derived GDNF can 
support innervation of skeletal muscle and is neuroprotective in SOD193A mice 
(Deshpande et al., 2006; Li et al., 2007). Likewise, in a separate study 
improvement of symptoms in a mouse model of ALS was due to increased 
expression of the muscle specific mir-206 (Williams et al., 2009). This microRNA 
is important for the production of a fibroblast growth factor (FGF) dependent 
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reinnervation signal at the neuromuscular junction. While this microRNA does not 
appear to play a role in the development of neuromuscular synapses, it does play 
an important role in their maintenance.  
The third category of pathogenic mechanisms includes alterations in 
ubiquitous processes that are especially important for motor neuron health. 
Specifically, response mechanisms dealing with RNA or protein metabolism may 
be at fault. The inclusions in ALS have garnered considerable attention. A major 
debate in in the field of ALS is whether inclusions represent a cause of toxicity, a 
protective sequestration of toxic proteins, or just pathological phenomena that 
play no role in disease. There are multiple forms found in ALS including Bunina 
bodies, whose major component is Cytostatin C and Hyaline Conglomerate 
Inclusions, which contain SOD1 (Okamoto et al., 2008). However, the most 
common and specific are ubiquitin inclusions (UBIs).  These often take the form 
of Lewy Body-like inclusions (LBIs) and Skein-like inclusions (SLIs). Since 2006 it 
has been apparent that the major component of these inclusions is TAR DNA-
Binding Protein 43 (TDP-43) (Neumann et al., 2006). Other ALS proteins 
commonly found in ubiquitin inclusions in ALS are Fused in Sarcoma / 
Translocated in Liposarcoma (FUS/TLS), Optineurin (OPT), and Ubiquilin 2 
(UBQLN2) (Kwiatkowski et al., 2009; Vance et al., 2009; Maruyama et al., 2010; 
Deng et al., 2011).  
A common feature of many proteins involved in ALS is that mutations 
cause their accumulation in cellular inclusions, suggesting that normal protein 
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degradation mechanisms have failed. One of these pathways, the ubiquitin 
proteasome pathway works by adding small tags to proteins composed of 
ubiquitin. These tags signal for the protein’s targeting to the proteasome where it 
is degraded. In an alternate pathway, autophagy, cellular components including 
protein aggregates are targeted for their breakdown in the cell’s lysosomal 
system. One ALS gene found in ubitquitin inclusions, UBQLN2, is itself 
responsible for linking ubiquitin ligases to the proteasome. Interestingly, UBQLN2 
inclusions commonly contain TDP-43, FUS/TLS, and OPT. Mutations in Valosin 
containing protein (VCP) were identified in 5 patients with FALS (Johnson et al., 
2010). This gene is an AAA+ ATPase that appears to play multiple roles in 
protein degradation through regulating both autophagy and proteasomal 
pathways (Ju and Weihl, 2010). These findings suggest that faulty protein 
degradation mechanisms might be an initiating factor in ALS.   
A revolution in the field occurred when TDP-43 was found to be the major 
component of ubiquitin inclusions in ALS and Frontotemporal Lobar degeneration 
with ubiquitin inclusions (FTLD-U). It was hypothesized that this pathology was a 
specific marker of ALS/FTLD-U. It was later discovered that while TDP-43 
pathology is present in almost all cases of ALS and FTLD-U, it is also present in 
a large percentage of other conditions such as Alzhiemer’s disease, Parkinson’s 
disease, and Huntington’s disease (Baloh, 2011). Additional conditions that 
contain TDP-43 pathology are Dementia and Inclusion body myositis (IBM). 
These conditions, deemed TDP-43 proteinopathies, have created quite a 
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quandary in the field. It still not clear how TDP-43 pathology could be so 
widespread throughout neurodegenerative diseases that have such different 
clinical presentations and courses.  
Multiple studies have suggested that the inclusions themselves are toxic. 
These studies overexpressed ALS proteins in their wild type and mutant forms 
and showed increased inclusions, neurotoxicity, and functional impairment. 
However, experimentally separating inclusion formation as a cause of toxicity has 
proven to be very challenging. In the case of TDP-43, it seems that its 25 kDa 
caspase cleavage fragment is the major component found in UBIs (Rohn and 
Kokoulina, 2009). This fragment is nonfunctional, but when overexpressed can 
cause inclusion formation and toxicity without affecting the localization or function 
of wild-type protein. However, in mouse models of TDP-43 overexpression, there 
has been a disconnect between the inclusion formation and the presence of 
functional defects (Igaz et al., 2011). Additionally, in several notable cases, 
overexpression of mutant protein has been phenotypically indistinguishable from 
overexpression of wild-type protein suggesting that that while inclusions are a 
hallmark of pathology in ALS, they may not be the primary cause of the functional 
deficits seen in the disease (Tatom et al., 2009; Wegorzewska et al., 2009; Xu et 
al., 2010; Zhou et al., 2010; Wils et al., 2010; Wang et al., 2010; Ya-Fei Xu, 
2011). 
If instead these protein aggregates function in a dominant negative 
fashion, then their presence indicates simply that they cause a progressive 
! 14 
depletion of their components elsewhere in the cell. Thus, the functions of these 
proteins are deficient causing disease. For example, TDP-43 and FUS are 
normally present in the nucleus, but in ALS become targeted to UBIs. Mutant 
TDP-43 has been proposed to bind wild-type (WT) protein, sequestering it in 
UBIs and causing a depletion of nuclear protein (Winton et al., 2008; Barmada et 
al., 2010; Igaz et al., 2011). Many of the identified mutations in FUS/TLS are in a 
noncanonical nuclear localization sequence in the C-terminus of the protein 
(Dormann et al., 2010). These mutations appear to impair Transportin-mediated 
nuclear import of the protein causing its redistribution to the cytoplasm.  
Alternatively, it has been proposed that mutations make the proteins 
nonfunctional and their targeting to UBIs is due to their increased sensitivity to 
damage and unfolding. The finding that heat shock factor-1 (HSF-1) is a major 
factor in modulating the aggregation of TDP-43, highlights this idea (Zhang et al., 
2011). HSF-1 is a component of the unfolded protein response pathway (UPR). 
Knockdown of HSF-1 potentiates the aggregation of TDP-43 mutants, while 
having little affect on wild type TDP-43. Thus, it appears that TDP-43 mutant 
proteins are incorporated into inclusions because their increased intrinsic 
propensity to unfold exceeds the ability of normal response mechanisms to refold 
and/or clear them.  
RNA metabolism has emerged as a common function of multiple ALS 
proteins. ANG is a ribonuclease specific for tRNA, and it also is plays a role in 
ribosomal RNA transcription (Hiroko Kishikawa, 2008; Yamasaki et al., 2009). 
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Senataxin, (SETX) is a DNA/RNA helicase with strong homology to RENT1 and 
IGHMBP2, both of which have shown roles in RNA processing. SETX has been 
shown to function in transcription termination and both splicing efficiency and 
specificity (Suraweera et al., 2009; Brow, 2011; Skourti-Stathaki et al., 2011).  
Much insight regarding the roles of RNA processing ALS has been gained 
through the study of RNA binding proteins such as TDP-43 and FUS/TLS. TDP-
43 is important for maintenance of the levels of its target mRNAs through both 
splicing and RNA stabilization. TDP-43 has many RNA targets, several of which 
are responsible for synaptic development and functioning (Sephton et al., 2011; 
Xiao et al., 2011). One of these targets, histone deacetylase 6 (HDAC6), is 
bound and stabilized by both FUS and TDP-43 in vitro (Fiesel et al., 2010; Kim et 
al., 2010). In cell-based models, knockdown of TDP-43 results in impaired neurite 
outgrowth and decreased HDAC6 expression (Fiesel et al., 2011). Replacement 
of HDAC6 can rescue these defects. In ALS, TDP-43 mRNA targets were found 
to be mis-spliced or downregulated in correlation with intron length (Polymenidou 
et al., 2011; Xiao et al., 2011). Some, of these targets are also themselves 
important for protein degradation pathways and RNA processing. Interestingly, 
TDP-43 loss-of-function mutation may be upstream of its incorporation in 
inclusions, as TDP-43 target ATG7 has been shown to be a key regulator of 
autophagy (Juhasz et al., 2007; Bose et al., 2011). 
It is now clear that many non-neuronal cells have important roles in the 
pathogenesis of ALS. The inclusions present in many forms of ALS are present 
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not just in motor neurons but also in non-motor neurons and glial cells (Zhang et 
al., 2007; Geser et al., 2008). Though inclusions have not been found in the 
muscle tissues of ALS patients, ubiquitin inclusions containing TDP-43 have 
been identified in several myopathies (Weihl et al., 2008; Salajegheh et al., 2009; 
Lain et al., 2010). The role of muscle cells as a source of key supportive signals 
in health and aberrant signals in disease was discussed above.  
Glial cells are now widely accepted as a major factor in the progression of 
ALS (Boillee et al., 2006). In SOD1 mouse and cell-based models it has been 
shown that glial expression of mutant SOD1 can impair motor neuron health 
(Ilieva et al., 2009). These cells are normally responsible for many supportive 
functions to neurons that might be lost in ALS.  For example, early studies 
suggested that mutant SOD1 expression in astrocytes led to a potentiation of 
glutamate excitotoxicity. This appears to be due to the down-regulation of the 
astrocyte glutamate transporter (EAAT2/GLT1) as well as the loss of signals to 
the motor neuron regulating expression of the protective glutamate receptor 
(GluR2) (Howland et al., 2002; Boston-Howes et al., 2006; Van Damme et al., 
2007). In addition, an important transcriptional regulator of antioxidant pathways, 
nuclear factor erythroid-2 related transcription factor 2 (Nrf2), is down-regulated 
in SOD1 mutant cells (Kirby, 2005).  
Alternatively, damage due to mutant SOD1 in astrocytes and microglia 
might coordinate to promote disease progression due to their production of pro-
apoptotic signaling molecules, complement, and reactive oxygen species (Di 
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Giorgio et al., 2007; Lobsiger et al., 2007; Marchetto et al., 2008; Ferraiuolo et 
al., 2011).  Nevertheless, the role of glial dysfunction in ALS is quite likely due to 
a combination of both loss of supportive functions and a gain of toxic function. 
Additionally, signaling between glia and motor neurons is a complex crosstalk, 
and it is increasingly clear that in ALS there are multiple defects on both sides of 
the conversation. There are direct effects of mutant proteins on organelle 
functions as well as transcriptional alteration of many genes (Kirby, 2005; Ferri et 
al., 2006; Lobsiger et al., 2007; Ferraiuolo et al., 2007; Vargas et al., 2008). 
Thus, the root cause dysfunction lies not simply in the alteration of any single 
process or gene, but rather in the disruption of the interplay between many 
signaling pathways.   
1.1.6  Discussion  
Though knowledge of the molecular mechanisms of ALS still hasn’t 
resulted in a cure, progress has accelerated with the number of genes associated 
with the disease growing rapidly. The pathological features of the disease such 
as protein accumulations, cell loss, and glial cell abnormalities have been known 
for nearly 140 years. The goals since then have been to connect these 
alterations with defects in molecular pathways. This has proven to be very 
challenging.  
Nevertheless, the elucidation of processes involved in the ALS has 
provided several features that are generalizable and also processes upon which 
the discovered genes appear to converge. For instance, considerable evidence is 
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growing to support the interplay of RNA metabolism, protein degradation, and 
altered cellular trafficking as key factors in ALS. Though the role of non-neuronal 
cell types in ALS is best studied for SOD1 related cases, pathology is present in 
these cells in cases associated with many other genes. This suggests that their 
dysfunction may contribute to disease in these cases as well. This idea is 
supported by the finding that one of the drivers of glial cell dysfunction EAAT2 
identified as a modifier of SOD1 mediated ALS is also an mRNA target of TDP-43 
(Tollervey et al., 2011; Polymenidou et al., 2011). Additionally, ADAR2, which is 
involved in GluR2 mRNA editing is associated with TDP-43 pathology (Aizawa et 
al., 2010; Hideyama et al., 2010).  
Many questions still remain as evidence continues to mount on both sides 
of the debate regarding key factors of the disease. Specifically, the role of 
inclusions in disease, the functional consequences of gene mutations on protein 
function, and the site of initial insult are all topics of fierce study. One overarching 
question that is still being settled is what interaction these genes might have with 
one another in generating the disease. This is the key question that this thesis 







1.2  The use of Drosophila melanogaster for the study of neurodegenerative 
disease  
1.2.1  Neurodegenerative diseases  
 Neurodegenerative diseases are a leading cause of morbidity and 
mortality worldwide. Estimates place the number of those affected in the millions, 
and this number is predicted to grow in the developed world as life expectancy 
continues to rise (Ferri et al., 2005). The nervous system is undoubtedly the most 
complex system in the human body with over 100 billion cells and a myriad of cell 
types. Each of these is connected to around 10,000 other neurons placing the 
number of synapses at around 100 trillion (Williams and Herrup, 1988). This high 
level of cellular diversity is mirrored by the level of diversity of gene expression 
programs underlying them. The structural and functional complexity must be 
generated faithfully through development and maintained throughout life. It is not 
surprising then that dysfunction of even a small subset of these cells or 
processes can have drastic phenotypes. In some cases, mutation in a single 
gene can alter the entire spectrum of functions of the mind including memory, 
motor control, speech, sensation, and even personality.  
Knowledge regarding these diseases has grown at a staggering rate with 
the number of genes causing them growing on an almost daily basis. However, 
this knowledge has not been met by substantial improvement of therapeutics. 
Unfortunately, at this point the treatment of ailments like Huntington’s disease 
(HD), Alzheimer’s disease (AD), and ALS remains focused on symptom reduction 
! 20 
and is rarely influential to improvement of function or disease progression. In 
many cases this is because research has yet to fully elucidate the mechanisms 
of disease pathogenesis. Furthermore, a key issue that has limited progress is 
the fact that by the time of diagnosis, the functional deficits present are often 
indicative of structural changes (i.e. large-scale cell loss). Therefore, 
pharmacologic intervention at this point is unable to provoke a great enough 
physiological response in the remaining healthy cells to improve symptoms.  
In spite of the complexity that exists within the human nervous system, 
many years of research has discovered that there is still much that can be 
learned from the study of neurodegenerative disease in simpler model 
organisms. The fruit fly has been especially powerful in the study of human 
biology because it possesses numerous features that make its use in the study of 
neurodegenerative disease very advantageous. The nervous system of the fruit 
fly has many structural and physiological properties that are analogous to the 
human nervous system, while still being a degree of magnitude less complex. 
Furthermore, it controls a range of highly complex behaviors: including courtship, 
grooming, aggression, and locomotion.  Powerful tools exist for the generation 
and study of mutants that can be very informative to the understanding of normal 
gene function and also to the processes that exist in disease states. In this 
section I will discuss aspects of fruit fly biology that are relevant to the study of 
human disease, give some examples of how these features have been used, and 
outline some of the ways in which this data can be interpreted.  
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1.2.2  Genetic conservation 
At first glance, the fruit fly and human seem to be very different organisms. 
Firstly, in terms of size both of the organisms and their genomes, the fly pales in 
comparison to the much larger human. The Drosophila genome contains just 137 
million base pairs, 4% that of humans (Rubin, 2000). In terms of genes however, 
this difference is much less with an estimated 14,000 functional genes compared 
to ~20,000 for humans (Pennisi, 2007). In the adult over 12,000 of these genes 
are expressed (Graveley et al., 2010). Alternative splicing exists for 7473 genes, 
which is 61% of the genome compared to around 95% for humans. The overall 
similarity of the products is even more striking with 60% of genes conserved 
between fly and humans (Rubin, 2000). Importantly, more than 74% of genes 
identified in human disease have at least one homolog in the fruit fly (Reiter, 
2001; Chien et al., 2002). In many instances the genes themselves are well 
conserved and the genetic pathways nearly identical. This high level of genetic 
conservation has been made useful in many areas of study.  
1.2.3  Drosophila life cycle 
 The Drosophila life cycle contains several distinct stages spanning 10-12 
days at 25°C (Greenspan, 2004). Adult females lay eggs that undergo 
embryogenesis for approximately one day. Embryogenesis is followed by three 
sequential larval stages, concluding with the wandering third instar larval stage, 
during which the larva crawls out of its food source and begins the immobile 
pupal stage [Figure 1.1]. During pupal development, a drastic metamorphosis 
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takes place over the course of the next five to seven days. Finally, adults emerge 
from their pupal cases. Females can mate as soon as 6 hours after eclosion.  
1.2.4  Development and anatomy of the Drosophila Nervous system 
 In reality, the term “Drosophila Nervous System”, is actually quite 
imprecise because the embryonic, larval, pupal, and adult systems are each 
distinct in their morphologies [Figure 1.2]. Importantly, while some structures are 
reused in later stages, metamorphosis signals the death of much of the larval and 
embryonic structures, and therefore the structures that exist in the pupal and 
adult nervous system are largely composed of new cells (Truman, 1990). 
Neurogenesis begins during the transition between embryonic stage 8 and 9 
when the first ectoderm-derived neuroblasts arise within the developing germ 
band (Hartenstein, 1984). These cells undergo a series of divisions giving rise to 
Figure 1.1. The life cycle of Drosophila melanogaster. Within hours after being laid, 
fertilized eggs hatch as embryos. This stage is followed by three larval stages and 
commences in pupation. Image reproduced from (Flymove.com). 
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ganglion mother cells and eventually to neurons. Neuroblast derived cells include 
the neurons and glia that compose the central nervous system (Klambt and 
Jacobs, 1991; Colonques et al., 2007). The first set of cell divisions takes place in 
the embryo giving rise to primary neurons (Ito, 1992; Lin and Lee, 2011). These 
cells condense and a distinguishable brain structure appears when the 
embryonic brain and ventral nerve cord detach from the ectoderm. This structure 
enlarges considerably as it is populated with neurons. The adult brain is 
populated mainly with neurons from a second set of neuroblast cell divisions 
which begin during the second instar stage (Pereanu, 2006). The GMCs from 
these cell divisions do not terminally differentiate until the pupal stage, when 
remodeled primary neurons from the larvae are integrated with secondary 
lineages into adult circuits (Truman, 1990).   
The structure of the Drosophila brain displays anatomical differences 
specific tor the life stage in which it exists (Nichols, 2006). The embryonic and 
larval CNS is composed of two brain lobes, attached optic lobes, and a ventral 
nerve cord. In the adult, several structures are added as the ventral nerve cord 
changes to accommodate this change in body morphology. Specifically, the larval 
body plan is replaced by compartments: the head, thorax, and abdomen. In the 
head, the optic lobe now increases in size. The proximal region of the ventral 
nerve cord becomes the subesophogeal ganglion. The brain must accommodate 
for the narrow space between the head and thorax by forming the central 
commissure to connect to the thoraco-abdominal ganglion (ThAGgl). 
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1.2.4  The Drosophila Motor System 
The Drosophila nervous system displays several key structural differences 
when compared with that of vertebrates. In contrast to mammalian systems the 
cell bodies of the sensory neurons reside in the periphery near the sensory 
organs from which they deliver information, instead of in a dorsal root ganglion 
[Figure 1.3] (Landgraf et al., 2003b; Sánchez-Soriano et al., 2007).  The 
neuronal cell bodies of the Drosophila motor system reside in the outer cortex of 
the VNC. Later in the adult ThAGgl, they reside in crests of cells excluded from 
the neuromeres rather than in a surrounding cortex (Baek and Mann, 2009).  
Figure 1.2. The Drosophila CNS throughout development. (A-B) The embryonic and larval 
CNS is composed of the VNC and 2 Central brain lobes. (C) During the pupal stage the CNS is 
revised as the Optic lobes grow in size and the brain structures become more defined as the supra 
and subesophageal ganglia. (D) In the adult brain the central commissure connects the head 
structures with the thoracoabdominal ganglion. (Nichols, 2006).  
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 These are multipolar cells whose dendrites arborize within the dorsal 
neuropile. These receive input from the of the giant fiber neurons (GFN) in the 
central brain and also from peripherally synapsing interneurons (PSIs) within the 
VNC (Tanouye and Wyman, 1980). Cholinergic and also GABAergic inputs exist 
as well, though the neuronal input of these central neurons are poorly understood 
(Baines and Bate, 1998; Rohrbough and Broadie, 2002). Motor neurons send 
their axons to the periphery where they form NMJ synapses.   
In the embryonic motor system a stereotyped arrangement of 30 muscles 
exists within each hemisegment of the body wall (Collins and Diantonio, 2007). 
These receive input from a total of 32 motor neurons. The axons of Drosophila 
motor neurons leave the ventral nerve cord in one of three nerves: the 
A B
Figure 1.3. The organization of the Drosophila VNC. (A) Interneurons (IN) and Efferent motor 
neurons (EN) reside in the cortex of the VNC and project both dendtrites and axons into the 
neuropile. Neuronal fibers project to their targets through one of several nerves (N). Sensory 
nerves (SN) reside in the periphery and project centrally. (B) In the adult the equivalent of the 
VNC, the ThAGgL neuronal cell bodes are not surrounding the neuropile but rather are located 
within crests of cells between neuromeres (T1-T3 and A). Arrows point to the glutamatergic motor 
cells marked by Vglut-GFP. (Landgraf et al., 2003b; Baek and Mann, 2009). 
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intersegmental nerve (ISN), the segmental nerve (SN) and the transverse nerve. 
These classes can be further subdivided by the target areas which they innervate 
(Butler and Tear, 2006). The ISN neurons can innervate ventral (ISN b or d), 
dorsal (ISND) and lateral (ISNL) muscles [Figure 1.4]. Likewise the segmental 
neurons can innervate lateral (SNa) and ventral (SNc) muscles. Although the cell 
bodies of motor neurons may be grouped based on their target, as in vertebrates, 
this does not correlate as well with target identity as the location of their dendritic 
trees within the neuropile. The neurons which innervate each muscle group have 
their dendritic trees in a specific location, forming what has been called a 
“myotopic map” (Landgraf et al., 2003a). Although some motor neurons target 
different and/or multiple muscles during the transition from embryo to larva, most 
embryonic motor neurons are conserved in larvae with respect to soma position, 




Figure 1.4. The neuromuscular circuitry of the Drosophila larva. Schematic depicts the 
nerves and muscle fibers of one hemisegment. Motor neurons leave the CNS as part of the 




1.2.5  Drosophila NMJ synaptogenesis 
 Drosophila motor neurons are targeted to specific muscles using a 
combination of genetic properties of the neuron and also axon guidance cues 
produced in the muscle. The process whereby motor neurons are targeted to 
specific muscles and form synapses is accomplished by late embryogenesis. The 
mechanisms controlling the assembly of this circuitry are largely conserved and 
include a combination of homeobox and lim-homeodomain proteins (Butler and 
Tear, 2006). During the larval period there is a large increase in muscle size that 
must be met by an increase in synaptic input and therefore an increase in 
synaptic size. Thus, the Drosophila neuromuscular synapse has been a 
historically important model for the study of synaptic growth (Collins and 
Diantonio, 2007). Synaptic growth and plasticity is thought to underlie essential 
features of memory and learning (Davis, 2011). Additionally, synaptic dysgenesis 
can be a feature of neuromuscular disease, and therefore, the study of synaptic 
development in Drosophila is relevant to human health (Frey et al., 2000).  
 Glutamatergic synapses are the major excitatory neurotransmitter in the 
human brain. The NMJ of Drosophila is a glutamatergic synapse, unlike those in 
mammals, which are cholinergic (Johansen et al., 1989). The NMJ synapse has 
a characteristic structure including neuronal branches and synaptic boutons 
[Figure 1.5] (Collins and Diantonio, 2007). Synaptic boutons are sites of motor 
neuron attachment to muscle and also contain active zones, which are sites of 
neurotransmitter release. Motor neurons project their axon growth cones from the 
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VNC as early as stage 12 of embryogenesis and synaptogenesis initiates by 
stage 15 (Prokop, 1999). The cellular contact between the presynaptic terminal 
and post-synaptic muscle is provided by cell adhesion molecules (CAMs), such 
as Fasciculin2 (Fas2). 
 Presynaptic active zones in Drosophila display a high degree of 
conservation, although the ultrastructure of the presynaptic active zones are 
species specific (Zhai, 2004). In Drosophila, the active zones take the shape of a 
T-bar, and as in humans, this structure is the site of vesicle concentration in close 
proximity to the presynaptic membrane. Presynaptic markers include: 
components of the active zone apparatus (NC82/Bruchpilot), vesicle proteins 
(cysteine string protein), and markers of presynaptic calcium channels 
(Cacophony) to name a few (Wagh et al., 2006; Kittel et al., 2006). While human 
synapses have an extensive basal lamina within the synaptic cleft, this structure 
is not apparent in Drosophila.  
Synaptic terminals are endowed with glutamate even before 
synaptogenesis, and synaptic transmission is detectable as soon as 30 minutes 
after contact (Prokop, 1999). Presynaptic release of glutamate is thought to drive 
the clustering and upregulation of glutamate receptor (GluR) (Chen and 
Featherstone, 2005). Scaffolding molecules such as discs large (DLG) combine 
with CAMs, Shaker potassium channels, and GluRs to form a postsynaptic 
density (PSD). The postsynaptic density in Drosophila is highly conserved, as 
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roughly 96% components of the human PSD have homologs in Drosophila (Faith 
L W Liebl, 2008).  
 
 
In addition to the neuronal fiber identity (i.e. ISN, SN, TN), efferent 
neurons in the Drosophila larva are further divided into types I-III based on their 
functional and morphologic properties (Prokop, 2006). Type I motor neurons are 
glutamatergic. These neurons are further subdivided into types Ib and Is. The 
synaptic boutons of Ib neurons are larger and exist only on single muscles. In 
contrast, 1s neurons project to several muscles and have smaller boutons. Type 
1b neurons are specialized for low threshold, precise movements, while type 1s 
neurons are specialized for high threshold, powerful movements (Choi and Park, 
2004). Type II neurons play a modulatory role and each innervates as many as 
Figure 1.5. The Drosophila Larval NMJ Synapse. (A) The muscle 4 NMJ of a third instar 
larva displaying type Ib synapse (white arrow) and type Is synapse (blue arrow). The neuronal 
membrane marked by horshradish peroxidase (HRP) and presynapse marked by (CSP). 
 (B) The synaptic markers bruchpilot and GluRC are in apposition at the synapse. (C) The T-
Bar structure of the Drosophila active zone. (D) Transmission electron microscopy of the 
synapse. N=neuron, M=muscle, black arrow=Active zone. (Zhai, 2004; Prokop, 2006; 2006; 






10 muscles per hemisegment (Hoang, 2001). Their synaptic terminals release 
octopamine. Only two type III neurons exist per hemisegment and each forms 
connections with only one muscle per neuron. The neurotransmitter used by type 
III neurons is unknown, although they contain a number of peptides including 
insulin like peptide and leukocinin1 (Landgraf et al., 2003b). Most body wall 
muscles are innervated by more than one motor neuron but no muscle is 
innervated by two axons with the same bouton type (Hoang, 2001). 
The mechanisms of synaptic growth are complex, with many signaling 
pathways involved. Anterograde signaling is provided from the wingless (Wg), a 
homolog of the mammalian Wnt pathway (Korkut and Budnik, 2009). This protein 
is secreted from the neuron and interacts with its receptor Frizzled 2 (DFz2) and 
co-receptor Arrow (Marqués, 2005). The Wg receptor complex is located on both 
pre- and post-synaptic surface. The downstream pathways following receptor 
activation differ in the neuron and the muscle. In the neuron, receptor binding 
leads to activation of Dishevelled (DVL), a negative regulator of shaggy (Sgg), 
the Drosophila homolog of GSK-3β (Miech et al., 2008). Downstream of this is 
Futsch, a homolog of microtubule associated protein 1B (MAP1B), which is 
normally inhibited through phosphorylation by Sgg. Futsch is responsible for 
microtubule stabilization and essential for maintenance of synaptic size (Franco, 
2004). Wg activity releases the inhibition of Futsch by Sgg. Postsynaptically, 
receptor binding by wingless leads to DFz2 receptor endocytosis and cleavage 
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(Mathew, 2005). The DFz2 receptor then translocates to the nucleus where it 
regulates transcription.  
An important retrograde signal is the TGFβ/BMP pathway member glass 
bottom boat (Gbb). This molecule binds to presynaptic type II BMP receptor 
wishful thinking (Wit), leading to its recruitment and phosphorylation of type I 
BMP receptors thickvein (Tkv) or saxophone (Sax) (McCabe et al., 2003). Type I 
BMP receptors in turn phosphorylate Smad proteins, which in coordination with 
co-Smads, are retrogradely trafficked to the cell body from the synapse. This 
complex translocates to the nucleus to regulate gene transcription. This pathway 
is a positive regulator of synaptic size as wit, gbb, and tkv mutants display 
decreased synaptic size. Few transcriptional targets of the BMP pathway have 
been identified. One of these, Trio, is a Rac GEF important for the dynamics of 
the actin cytoskeleton (Ball et al., 2010).  
A potent modifier of synaptic growth is Highwire (Hiw), which regulates 
both BMP signaling and signaling by Wallenda (Wal) (Fulga and Van Vactor, 
2008). Highwire is a very large protein that has been conserved in mammals. 
Highwire is an E3 Ubiquitin ligase that binds BMP pathway Co-Smad Medea, 
leading to its degradation (McCabe et al., 2004). Hiw loss-of-function mutants 
have very large NMJ synapses that are restored to normal size by inhibitory 
mutation of BMP receptors. Thus, Hiw is thought to function through inhibition of 
BMP signaling. Alternatively, it may act on Wallenda, which is a well conserved 
mitogen-activated protein (MAP) kinase kinase kinase (MAPKKK) (Collins et al., 
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2006; Wu et al., 2007). Wallenda acts through the JNK MAPK pathway leading to 
activation of the AP-1 complex of transcription factors, Jun and Fos. 
1.2.6  Modeling Neurodegenerative disease in Drosophila   
 Many tools exist for gene manipulation in Drosophila (Venken and Bellen, 
2005). Classical techniques and also new technologies have been employed to 
decipher the molecular mechanisms of neurodegeneration (Muqit and Feany, 
2002). Especially advantageous has been the short lifespan of the organism (~60 
days) and also the ease with which the nervous system may be accessed. 
Multiple tools exist for the generation of mutants that can be employed to 
understand the normal functions of genes. Additionally, misexpression studies 
using human and Drosophila WT and mutant proteins can be used to understand 
the functional relevance of disease specific mutations.  Lastly, genetic screens 
can be used for the quick in vivo identification of downstream targets. 
 Loss of function mutants may be generated by a number of ways (Adams 
and Sekelsky, 2002). Common techniques used for the generation of mutants 
include chemical and P-element insertional mutagenesis. In fact, large-scale 
gene disruption libraries have been created and these have successfully inserted 
P-elements into many genes (Thibault et al., 2004; Bellen et al., 2011). Thus, 
studying the gene of interest may be as easy as ordering a stock from the 
repository. Drosophila mutants may be analyzed for many disease relevant 
phenotypes such as defects in lifespan, locomotor ability, synaptic morphology, 
and synaptic electrophysiology (Hirth, 2010). Furthermore, these mutants are 
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also used for epistasis experiments to understand the genetic relationships 
between disease genes.  
One notable example of this comes from the study of genes involved in 
Parkinson’s disease. The study of PTEN-induced kinase 1 (Pink1) and parkin 
(PARK2) in Drosophila provided a genetic model for the interaction of these 
genes (Park et al., 2006; Clark et al., 2006). Drosophila mutants of pink1 and 
parkin both display dopaminergic neuronal degeneration and mitochondrial 
defects. Epistasis experiments using these mutants placed pink1 above parkin in 
a genetic pathway influencing mitochondrial remodeling and neuronal health 
(Park et al., 2009).  
  Misexpression studies commonly employ binary expression systems to 
drive protein expression in a tissue-specific pattern. The most widely used 
system, the GAL4-UAS system, works when tissue specific promoters drive 
expression of the yeast GAL4 protein (Duffy, 2002). GAL4 binds to its upstream 
activating sequence (UAS), which is linked upstream of the gene of choice. GAL4 
drivers are available for many useful tissues including:  the entire brain (Elav-
GAL4), motor neuron (Vglut-GAL4), compound eye (GMR –GAL4), or mushroom 
body (OK107-GAL4). One of the many uses of GAL4 drivers is to rescue mutants 
in a tissue specific manner in an attempt to identify the site of gene action for a 
particular phenotype. Conversely, overexpression of genes in various tissues in a 
WT background can provide useful phenotypes.  
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Expression in the Drosophila eye has been widely used as a model for 
neuronal death and degeneration (Fortini and Bonini, 2000; Bonini, 2003; Marsh 
and Thompson, 2006; Lessing and Bonini, 2009). The Drosophila compound eye 
has a highly precise and stereotyped structure composed of exactly 800 
ommatidia, each containing 8 photoreceptor neurons (Jackson, 2008). The 
morphology of the compound eye is very sensitive to cellular insults, and when 
disrupted can be viewed externally. Phenotypes range from subtle roughening of 
the retinal surface, but can be as severe as large-scale loss of photoreceptors 
and necrosis, which can be viewed as black spots on the surface of the eye 
(Ghosh, 2004). Furthermore, microscopy of the internal eye structures can reveal 
cellular defects. Since the eye is dispensable for viability, neurodegeneration 
phenotypes can be viewed without compromising the survival of the animal.  
For instance, overexpression of the Alzheimer’s gene Tau in the 
Drosophila eye causes a rough eye phenotype, which is due to a disorganization 
of photoreceptor neurons and increased apoptosis (Wittmann, 2001). 
Additionally, these neurons contain hallmark aggregates of neurofibrils and 
cellular vacuolization which are characteristic signs of neurodegeneration 
(Jackson et al., 2002). Using epistasis experiments, studies were later able to 
implicate the Wingless pathway as a modifier of tau toxicity in Alzheimer’s 
disease.  
 Genetic modifier screens have also been used to help identify the 
mechanisms of neurodegeneration. Once again large repositories containing 
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libraries of genetic tools are readily available. Deficiency libraries are collections 
of mutant flies that have large, but well defined deletions throughout the genome. 
Deficiency screening and RNAi screening are methods for down-regulation of 
potential interactors (Ryder, 2004; Dietzl et al., 2007; Ryder et al., 2007; 
Flockhart et al., 2011). Alternatively, EP libraries are collections of mutant flies 
that have UAS containing P-elements inserted upstream of genes (Rorth, 1996; 
Toba et al., 1999). These can be used as a high-throughput method to 
interrogate the genome for modifiers by up-regulation of potential interactors 
(Rorth et al., 1998; Rezával et al., 2008). Notable genetic screens have provided 
useful information for neurodegenerative diseases such as ALS, Spinocerebellar 
Ataxia (SCA), and Huntington’s disease (Bilen and Bonini, 2007; Ritson et al., 
2010; Schulte et al., 2011). 
1.2.7  Limitations  
Although the nervous systems of Drosophila and humans share a large 
number of features, there are limitations to the applicability of Drosophila as a 
discrete model of neurodegenerative disease. Drosophila neurons, while they are 
largely ensheathed by glial cells, are unmyelinated (Freeman and Doherty, 
2006). Disorders of myelination such as multiple sclerosis are therefore poorly 
modeled in the fly. Furthermore, due to the lack of an adaptive immune system, 
Drosophila is a poor model of choice for diseases for which autoimmunity is a 
putative etiology. 
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While genetic conservation is high there still exists divergence in several 
key aspects of genomic structure. Above, the genetic conservation of the 
Drosophila genome in humans was discussed. However, several caveats must 
be considered. Importantly, there are genes implicated in neurodegenerative 
disease that have no clear homolog in Drosophila and also genes implicated in 
fly neurodegeneration that have no clear homolog in man. Furthermore, although 
there is a reasonably high degree of conservation in the coding sequence of 
genes, there is a much greater divergence in the noncoding sequence (Hong et 
al., 2006; Kim et al., 2006). While a large number of Drosophila genes are 
alternatively spliced, human genes have nearly double the number of introns. 
The median intron length is similar with the median length at ~80bp versus 
~100bp for humans [Figure 1.6]. Mean intron length is much smaller in 
Drosophila with mean intron length a third that of humans. The distribution of 
Drosophila intron lengths is very narrow, whereas the distribution for human 
introns is much wider and contains a much greater number of very large introns 
with some introns at 10,000 bp or more (Hong et al., 2006; Kim et al., 2006). 
The interspecies differences in intronic structure could potentially limit the  
relevance of the study of disease for which splice isoform specificity plays a 
major role. For example, the human MND, spinal muscular atrophy (SMA) is 
caused homozygous recessive mutations in the SMN-1 gene (Burghes, 1997). 
Humans have a second SMN gene, SMN-2, but this protein is unstable and 
cannot compensate for the loss of SMN-1 (Lorson et al., 1999). The instability of 
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SMN-2 is due to a difference in the splicing efficiency between exons six and 
seven of the gene. Thus, splicing efficiency of SMN-2 is a potential  
 
target for improving SMN phenotypes (Cartegni et al., 2006). Unfortunately, this 
aspect of SMA biology is difficult to study in Drosophila because in the fruitfly 
there is only one SMN gene and it does not contain introns. Therefore, molecules 
that have been reported to intersect with SMN function by augmenting SMN-2 
exon 7 inclusion would be predicted to have no effect in the fly (Bose et al., 
2008). Although it would be possible to insert the WT human gene into the 
genome it is unknown if the mechanisms of SMN gene splicing are conserved, 
especially because the endogenous gene lacks introns. 
 Intron length divergence could also limit the quality of the results yielded 
from studying genes thought to play a role in splicing. Several notable studies in 











Figure 1.6 Intron length variation in Drosophila and Human. The distribution of Drosophila 
and human intron lengths contained within the 5’ untranslated region (5’ UTR), coding 
sequence(CDS), and 3’UTR. (Hong et al., 2006). 
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mammalian systems have suggested that depletion of the ALS protein, TDP-43, 
leads to a large down-regulation in a number of TDP-43 splicing targets 
(Tollervey et al., 2011; Polymenidou et al., 2011). This effect is most prevalent for 
those genes that have long introns. Due to the fact that mean intron length in 
Drosophila is much smaller, the number of genes that are affected by TDP-43 
depletion would be expected to be narrower. It would not be surprising to find that 
long-intron containing TDP-43 targets are unperturbed in Drosophila null 
mutants. Thus, based on models of TDP-43 function in long-intron splicing, 
studies of TDP-43 in the fruit fly will give a large but not entirely complete picture 
of the downstream repercussions of aberrant TDP-43 function in splicing.  
!
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Chapter 2 Materials and Methods 
2.1 Fly Husbandry  
2.1.1 Introduction 
 The cultivation and manipulation of Drosophila melanogaster in research 
laboratories was started at Columbia University. Thomas Hunt Morgan used this 
powerful model organism to develop the chromosomal theory of inheritance. 
Since then, Drosophila melanogaster has been a vital resource for the study of 
the mechanisms underlying development and disease. Several key features have 
made this model so successful. First, it has a fast generation time.  If a cross is 
stored at 25°C, third instar larva are available for study within 5-7 days and adults 
eclose as early as 10 days. Second, it employs the use of balancer chromosomes 
that contain multiple inversions. These act to prevent recombination and preserve 
mutations. Finally, the use of markers along with balancers allows one to track the 
chromosomal identity through successive crosses. This allows one to create 
complex crossing schemes and makes possible multiple genetic manipulations 
that are difficult to achieve in other model organisms.   
2.1.2 Materials 
 Fly stocks used in this thesis include the caz1 mutant. The tbphΔ23 mutant 
was obtained from Fabian Feguin (International Centre for Genetic Engineering 
and Biotechnology [ICGEB], Trieste, Italy) (Feiguin et al., 2009). Additional stocks 
include the transgenic UAS flies for WT TBPH, TDP-43, Caz, and FUS. 
Transgenic UAS flies lines containing ALS associated point mutations include 
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TDP-43M337V, CazR395G, CazP398L, FUSR522G, and FUSP525L. GAL4 lines used 
included C155-GAL4, GMR-GAL4, OK6-Gal4, and OK319-GAL4. Additional lines 
used were Df[2R]BSC660 (B#26512), UAS-LacZ (B#8530), and UAS-H1-YFP 
which was obtained from Alexei Tulin  (Fox Chase Cancer Center, Philadelphia, 
Pennsylvania, USA) (Pinnola et al., 2007). 
2.1.3 Methods 
The caz1 deletion mutant was generated by mobilizing the transposon 
insertion EP1564 to generate a small deletion, Df[1]383, that removed 2443 bp 
(57.6%) of the caz gene and 3251 bp of upstream sequence including the 
entire caz promoter [Figure 2.1]. Since this deletion also disrupts the nearby 
gene CG32576, a rescuing genomic transgene for CG32576 was also generated 
(see section 2.2.3). CG32576 genomic rescue flies were generated by insertion 
into the attP18 landing site on the X chromosome. This transgene was 








Figure 2.1. Schematic of caz1 mutant construction. The transposon EP 1564 was mobilized 
to create a small deletion Df[1]383 that removes 58% of the caz gene, caz promoter sequences, 
and disrupts the nearby gene CG32576. A rescuing transgene for CG32576 was inserted onto 
the Df[1]383 chromosome to create caz1 mutants. 
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For all experiments, hemizygous caz1/Y males were examined. A 
sequence-verified precise excision allele of EP1564 was uaed as a control for 
all caz experiments. For neuronal rescue of caz1 mutants, C155-Gal4, a pan-
neuronal GAL4 enhancer trap near the elav gene, was additionally introduced 
onto the caz1 chromosome by recombination. We use C155-Gal4 males as an 
additional control in these experiments. All Caz, FUS, TPBH, and TDP-43 
transgenes were inserted into the AttP40 site on chromosome III using phiC31 
targeted transgenesis  (Genetic Services). Identical expression was confirmed by 
western blot. 
2.2 Molecular Biology  
2.2.1 Materials and Methods 
Caz was amplified from cDNA clone LD 27761 (DGRC), TBPH was 
amplified from cDNA clone GH09868 (DGRC), TDP-43 was amplified from cDNA 
clone #30389805 (Open Biosystems), FUS was amplified from cDNA clone 
#2822692 (Open Biosystems). Mutations when appropriate were introduced in 
PCR primers or by site-directed mutagenesis (Stratagene). UAS transgenes were 
made by LR reaction into the Gateway cloning site within the pBI family of vectors. 
Untagged UAS transgenes were generated using pBI-UASC-G. Tagged UAS 
transgenes were generated with either pBI-UASC-VG or pBI-UASC-FG, 
To generate FLAG-tagged Caz genomic DNA, a 6.4-kb caz genomic DNA 
fragment that excludes the CG32576-coding region was cloned into the 
EcoRI/XbaI sites of pBI, and 3 copies of the FLAG epitope sequence were 
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inserted immediately after the caz start codon by PCR. To generate CG32576 
rescue genomic DNA, a 5.0-kb genomic DNA fragment excluding the Caz-coding 
region was subcloned from BAC CH322-46G07 (BACPAC Resources Center) into 
the EcoRI/XbaI sites of pBI.  
To construct pBI, gypsy insulator sequences were cloned flanking a 
multiple cloning site into the pUASTattB vector. pBI-UASC-G was constructed by 
introducing 10 copies of the UAS-binding sequence upstream of a Drosophila 
Synthetic Core Promoter sequence followed by a Gateway recombination 
cassette and an SV40 polyadenylation sequence into the pBI vector. pBI-UAS-VG 
and pBI-UASC-FG were constructed by introducing an N-terminal Venus-YFP 
sequence or FLAG epitope tag in frame with the gateway cassette of pBI-UASC-
G.  
2.3 Dissection of the Drosophila larval neuromuscular junction and brain 
2.3.1 Introduction 
  The Drosophila larva is an established model system used for the study of 
synaptic development and plasticity. The widespread use of the Drosophila motor 
system is due to its high accessibility. It can be analyzed with single-cell 
resolution. There are 30 muscles per hemisegment whose arrangement within the 
peripheral body wall are known. A total of 32 motor neurons per hemisegment are 
located in the VNC, and these neurons form synaptic attachments to the bodywall 
muscles in a pattern that has high fidelity. Using molecular biology and genetics, 
one can create transgenic animals or mutants. The developmental consequences 
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on the morphology and function of the NMJ can then be studied. Additionally, the 
cell bodies may be imaged and studied in the VNC.  
  In order to access the NMJ or brain for study, it is necessary to carefully 
dissect each larva by removing all internal organs while leaving the body wall and 
CNS intact. This technique is suitable to prepare larvae for imaging, 
immunohistochemistry, or electrophysiology. 
2.3.2  Materials 
Table 2.1 Materials used for Drosophila larval NMJ and brain dissection 
Material Name Company Catalogue Number Comment 
Stereomicroscope 
“Stemi” 2000 
Carl Zeiss MicroImaging Inc. 495101-9804-000   
Light Source KL 1500 
LCD 
Carl Zeiss 000000-1063-181   
3mm Vannas Spring 
Scissors 
Fine Science Tools Inc. 15000-0   
Dumont SS Forceps Fine Science Tools Inc. 11200-33 Long forceps 
Dumont #5 Forceps Fine Science Tools Inc. 11252-20 Short forceps 
SylGard 182 Silicone 
Elastomer Kit 
Dow Corning Corp. 3097358-1004 Used to make 
dissection 
plates 
Formaldehyde Sigma-Aldrich Inc. 252549-25ML   
Stainless Steel 
Minutien Pins -0.1 MM 
Diameter 
Fine Science Tools Inc. 26002-10  
 
Additional Materials: 
HL3 Dissection Buffer: (in mM) 70 NaCl, 5 KCl, 0.2 CaCl2, 20 MgCl2, 10 
NaHCO3, 5 trehalose, 115 sucrose, and 5 HEPES, pH 7.3. Sylgard Dissecting 
Plate: Sylgard is mixed gently to avoid bubbles (10:1) in a beaker. The mixture is 




2.3.3  Methods 
   All cultures should be grown at 25° C. HL3.1 dissection buffer should be 
prepared in advance.  A 50 ml aliquot of HL3.1 is kept on it on ice. Also, 15 ml of 
fresh 3.5% Formaldehyde is prepared in HL3.1 and kept on ice. A drop of cold 
HL3.1 is placed on the Sylgard dissection plate. The buffer acts to keep the 
animal from drying out and the coldness of the buffer solution helps to partially 
immobilize the animal making it easier to work with. 
   Using the long forceps, a wandering third instar larva is selected and 
placed in the drop of HL3.1. Short forceps are then used to grasp a minutien pin 

























































































































Figure 2.2. Dissection of the larval brain and bodywall musculature. (A) The anatomical 
landmarks used for dissection of the larval fruitfly. At arrows are the mouthparts, anterior 
and posterior spiracles, and trachea (B) A completed dissection of the brain and bodywall 
showing the exposed larval CNS including the brain and ventral nerve cord (VNC). (C) 
Higher magnification of image from B showing the stereotyped pattern bodywall musculature 
in each hemisegment. Adapted from(Brent et al., 2009).  
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usually try to crawl away from the pin stretching itself out and making it easier for 
one to place a pin squarely in the head of the larva near the mouthparts. The 
animal is stretched out lengthwise to help maximize the amount of exposed body 
wall achieved during cutting.    
   Spring scissors are used to make a horizontal incision just anterior to the 
posterior pin on the dorsal side of the larva. This incision should pierce the body 
wall and both trachea. One blade of the scissors is placed into the incision and a 
vertical cut is made along the dorsal midline toward the rostral end of the larva. At 
the rostrum of the animal, horizontal incisions are made to the left and right of the 
pin.  
   The organs are removed. Several additional drops of HL3.1 buffer are 
added to the larva. This will enable the organs to float up out of the body allowing 
you to remove them much more easily. First, the tracheal system is removed. 
Next, the forceps may be used to grasp the rest of the viscera and remove them. 
In previous steps left and right flaps were made in body wall. The flaps are now 
pinned in a clockwise order making sure to stretch the body wall both horizontally 
and vertically. The larval CNS is now apparent and may be left in place or 
removed. It is a matter of preference, but any additional viscera should now be 
removed.  
  Each animal is fixed in 3.5% formaldehyde in HL3.1 for 25 minutes. The 
animal is washed twice in HL3.1 for 5 minutes. The pins are removed and the 
larvae are transferred to a 1.5 ml tube containing 1X PBS.  Imaging of fluorescent-
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tagged proteins should be performed within two days because the fluorescent 
signal may degrade quickly. Otherwise, preparations that will be used for IHC may 
be stored for up to one week at 4°C.  
2.4 Dissection of the Drosophila Adult CNS 
2.4.1  Introduction  
 The Drosophila adult CNS is an important model for the study of behavioral 
genetics and neurocircuitry. Many features of the human brain are recapitulated in 
analogous systems in the fly brain. To access the fly brain it must be accessed by 
dissection. Unlike the larval brain, the adult brain spans two body compartments 
and is complicated by the presence of a firm exoskeleton. The dissection 
technique described here can be used to remove the total CNS of the adult fly.  
2.4.2 Materials 
 The materials used to dissect the adult brain are identical to those in 
section 2.3.2.  
2.4.3  Methods 
 The dissection methods used to dissect the adult brain were based on 
those described in (Wu and Luo, 2006). To anesthetize flies, the flies chosen for 
analysis are moved to a fresh vial of food and placed on ice, which will slow the 
movements of the flies for several minutes so that they can be manipulated more 
easily. Adult flies are removed from the vial using small SS forceps and 
suspended in a drop of buffer. First, the wings and legs are removed. Second, an 
incision is made using the small spring scissors to remove the abdominal 
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compartment. The cavity created at the posterior end of the thoracic compartment 
is extended anteriorly along the ventral body wall to just below the central 
commissure. The exoskeleton is now peeled away from the thoracic viscera.  
Unlike the larva, the viscera of the adult are much more tightly packed and 
the tissue is more difficult to distinguish. Therefore, the identification of landmarks 
is important to localize and preserve brain structures [Figure 2.3]. The viscera in 
the adult split through the muscle groups, which are much larger than in the 
larvae. The important landmarks in the thorax are muscle tissues that are 
positioned bilaterally on the ventral surface of the thorax. These are made by the 
first dorsal-ventral muscle group (DVM-I) that reside on the ventral side of the 
ThAGgl. Alternatively, the dorsal longitudinal muscles (DLMs) are also prominent 
on the dorsal side and directly anterior to them is the VNC.  In either case, viscera 
are removed from the thorax until these landmarks are exposed, and once the 
landmarks are visualized the VNC is identified between them and the muscles 
removed.  
To remove the head capsule, one pair of forceps is used to grasp the 
cuticle at the boundary of the retina and proboscis. Next, the proboscis is 
removed with the other forceps, leaving a cavity in the head. From this point, 
there are a few different ways to proceed. One effective way is to simply extend 
the cavity created by removing the proboscis anteriorly up and around the back of 
the head, where the central commissure is still surrounded by a collar of 




the VNC on the rear of the head. Turn the specimen around with the ventral side 
facing up. Now, extend the facial cavity down through the collar in the ventral side. 
Now the two halves of the exoskeleton are split and can be removed by pulling 
them laterally. Once the exoskeleton is removed, take care to remove the 
remaining retina from the optic lobes. The tracheal tissue can be removed now as 
well or can be left attached until fixation and IHC are completed. The adult brain 
preparations are fixed for 1 hour in 3.5 % Formaldehyde. 
2.5  Immunohistochemical Methods 
2.5.1  Introduction 
 The study of the structure and function of the Drosophila nervous system 
relies on the labeling of proteins using antibodies. The Drosophla larva and adult 








Figure 2.3 Important landmarks for adult VNC dissection.  (A-B) 3-D reconstruction of 
CNS, viscera and musculature of the adult fly. (A) the central brain(Br) descends into the 
thoracic cavity through the central commissure to the ThAGgl. The ThAGgl is surrounded 
anteriorly by the DVM-I muscles. (B) From the posterior view the ThAGgl rests anterior to the 
DLM muscle group and the proventriculus in red. (Jährling et al., 2010). 
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slightly to accommodate the thicker tissue. This procedure is modified from those 
described previously in (Brent et al., 2009). 
2.5.2 Materials 
Table 2.2. Materials used for Drosophila adult and larval IHC 
Material Name Company Catalogue Number 
Stereomicroscope “Stemi” 2000 Carl Zeiss MicroImaging Inc. 495101-9804-000 
Light Source KL 1500 LCD Carl Zeiss MicroImaging Inc. 000000-1063-181 
Dumont SS Forceps Fine Science Tools Inc. 11200-33 
Dumont #5 Forceps Fine Science Tools Inc. 11252-20 
Adams™ Nutator Mixer Becton, Dickinson and 
Company 
421105 
No.1 Precision knife X-Acto 3201 
No. 16 Blades X-Acto 216 
ProLong Gold Antifade reagent Invitrogen Corporation 36930 
 
Additional reagents:  
Rotating mixer, watch glass, and parafilm 
2.5.3 Methods 
The following solutions are prepared in advance: PBT (0.1 % Triton X100 
in 1X PBS), PBTB (0.2% BSA in PBT), and PBTN (2% NGS in PBTB).  
  Larvae are moved to a 1.5 ml tube containing PBT. Adult specimens are 
moved to a watch glass containing PBT and the watch glass is covered with 
parafilm. The specimens are washed twice for 15 minutes in the PBT. Washing is 
done by placing the 1.5 ml tube on a nutator mixer or the watch glass on a 
rotating mixer. Then, the PBT is removed and replaced with fresh solution. The 
specimens are washed/blocked in PBTB twice for 30 minutes and in PBTN twice 
for 15 minutes. They are then incubated in primary antibody diluted in PBTN at 
room temp for 1 hour or at overnight. Adult antibody staining is always performed 
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overnight at 4º C 
  The samples are rinsed twice with PBTB by adding and removing solution 
quickly. The samples are washed twice for 15 minutes in PBTB and once for 30 
minutes in PBTN. Secondary antibody and/or conjugated primary antibody diluted 
in PBTN are added to the samples and they are covered in tinfoil. Larval samples 
are incubated with secondary antibody for 1.5 hours at room temperature. 
Secondary incubation of adult CNS is always performed overnight at 4°C. The 
samples are rinsed twice with PBTB and washed twice for 15 minutes with PBTB.  
  Mounting is performed in glycerol if samples are to be imaged immediately. 
Alternatively, it is ideal to mount in Prolong Gold if samples are stored before 
imaging or if samples must be imaged multiple times. Prolong Gold is placed in a 
65ºC water bath for 2-3 minutes. An aliquot of Prolong Gold is taken and kept on 
a heat-block at 45-50º C.  
  To mount larvae, stained larval preps are transferred to PBT a watch glass. 
The animals are moved from the watchglass to a fresh slide containing 
glycerol/Prolong Gold for processing. The preparations must be cuticle side down. 
Any additional debris still present from the earlier steps is now removed. The 
head and tail are removed with an X-Acto knife. On another slide a small drop of 
glycerol/prolong is spread with clean forceps. The dissected animals are moved to 
this slide by their edge, taking care not to invert them. A cover slip is placed on 
the slide and the slide is sealed with nail varnish. Prolong Gold must be cured for 
at least 3 hours before imaging. Samples mounted in glycerol may be imaged as 
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soon as the nail varnish dries.  
 To mount adult samples, a bridge is created on the mounting slide by 
attaching two coverslips to the slide using nail varnish. The bridge slides create a 
channel in the middle of the slide so that the adult CNS morphology is not 
flattened when the final coverslip is attached. Once the nail varnish dries, Prolong 
Gold/glycerol is added to the channel. The samples are moved into the channel 
using forceps and any remaining tracheal or retinal tissue is removed. A coverslip 
is attached on top of the bridge and sealed with nail varnish. 
  Primary antibodies used to stain adult brains were mouse anti-flag (1:500) 
(Sigma-Aldrich) and rat anti-ELAV (1:500) (DSHB). The secondary antibodies 
used were anti-mouse Cy3 (1:200) (Jackson ImmunoResearch) and anti-rat Cy2 
(1:200) (Jackson ImmunoResearch). Larval NMJs were labeled with a mouse 
anti-CSP primary antibody 6D6 (1:200) (DSHB), anti-mouse Cy3 secondary 
(1:1000), and an HRP-Cy3 conjugate (1:400) (Jackson ImmunoResearch). 
Samples were mounted in ProLong Gold Antifade Reagent (Invitrogen).  
For motor neuron colabeling, OK319-GAL4 was used to drive the transgenes 
UAS-H1YFP and UAS-LacZ together with UAS versions of Flag-CAZ, Flag-FUS, 
Flag-FUSP525L, Flag-FUSR522G, Flag-CazR395G, or Flag-CazP398L.  
Immunohistochemistry was performed with primary antibodies mouse anti-
Flag (1:1000) (Sigma-Aldrich), rabbit anti-BGal (1:1000) (Cappel), and chicken 
anti-GFP (1:1000) (Abcam) and secondary antibodies anti-mouse Cy3 (1:1000) 
anti-rabbit Alexa Fluor 647 (1:1000), and anti-chicken Alexa Fluor 488 (1:2000). 
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2.6 Analysis of Drosophila Larval and Adult locomotion 
2.6.1  Introduction 
In all animals, simple behaviors like feeding, mating, and escape require 
the production of directed motion. Alternatively many neurodegenerative diseases 
cause age dependent decline in motor functioning and coordination.  The power 
of modeling human disease in Drosophila is that the phenotypes of disease are 
expressed much faster, reflecting the difference in generation time. Locomotion is 
a complex behavior, integrating many genes and neurons. In the larva, peristaltic 
impulses generated in the brain must be coordinated and delivered to muscle 
fibers for crawling. In the adult, these inputs are used in six-legged walking and 
also flying.  
Locomotor analysis is a useful tool for understanding the functional roles of 
genes in the Drosophila nervous system.  Mutations affecting a range of genes 
give rise to locomotor phenotypes, including mutations in genes with established 
roles in neuronal health, synaptic development, and axon guidance. Additionally, 
several Drosophila models of human neurodegenerative disease display defects 
in locomotor behavior suggesting that the functional outputs of disease are well 
recapitulated in the fly.  
2.6.2 Materials 
Larval Crawling Assay 
Petri dishes containing minimal agar   
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Adult Walking Assay 
A fly transfer apparatus is constructed by using parafilm to attach a 100 µl 
pipette tip to one end of a compatible rubber hose. A filter may be placed in 
between the pipette tip and hose to prevent flies from being inhaled by the user. 
The pipette tip is cut using scissors to accommodate a single fly.  A locomotion 
arena is constructed using a clear slide box top or comparable item. A cover for 
this arena is constructed by piercing a small hole in a clear plastic sheet. A fly 
selection chamber is constructed by attaching a small funnel to a 50-100 ml 
Erlenmeyer flask. A petri dish lid is used to cover the selection chamber.  
Adult Negative Geotaxis Assay 
Computer mouse pads, 100 ml graduated cylinder, light source, and timer. 
Additional materials include: stereomicroscope with video capture capability, 
illumination stage, computer, Final Cut 6.0 Software, Dynamic Image Analysis 
Software 3.4 2. 
2.6.3 Methods 
Larval Locomotor assay 
Larvae are selected and placed in a watch glass containing 1XPBS. To 
perform the assay, single larvae are place on a minimal agar plate and allowed to 
adjust for 30 seconds. The plate containing the larva to be analyzed is moved into 
view of the video capture apparatus. Using Final Cut Pro, a 60 second clip of 
locomotor behavior movement is collected. This clip is converted to Quicktime and 
analyzed using DIAS.  
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Adult walking Assay 
 Adult flies are selected and placed into a fresh vial. Since collection of 
these animals requires anesthetization, they should be allowed to recuperate for a 
minimum of 12 hours in the 25°C incubator. The flies to be analyzed are moved to 
the selection chamber and the cover is replaced. The locomotion arena is 
assembled by placing the slide box cover with its cavity facing upward and putting 
the cover on top with the hole over cavity. Single flies are selected using the fly 
transfer apparatus and placed through the hole in the chamber. The cover is slid 
to move the hole out of line with the cavity. After a 60 second acclimation period, 
one minute of locomotor behavior is recorded. The video is converted to  
Quicktime and analyzed using DIAS [Figure 2.4]. 
 Adult Negative Geotaxis Assay 
The animals to be analyzed are selected and groups of 10 are transferred 
to a fresh vial. These animals are allowed to recuperate from anesthesia for a 
minimum of 12 hrs at 25 C. One vial (ten flies) is transferred to the 100 ml 
graduated cylinder and the opening of the cylinder is covered with parafilm. After 
A B C
Figure 2.4. Quantitative analysis of adult locomotor behavior. (A) Single flies are allowed to 
explore the locomotion arena for 60 s. This motion is traced by DIAS (green highlight). (B) The 
locomotor trace is converted to a green line. (C) The location of the animal along the line from B 
is plotted over time, with 10 dots placed along the line each second.  
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a one minute acclimation period, animals are tapped to the bottom of the cylinder 
against a mouse pad to prevent the glass from breaking. The cylinder is placed 
underneath a light source and the flies are allowed to climb the side of the vial. 
Several parameters may be timed. These include: the time for half the flies to 
climb halfway up the cylinder, the time for 1 fly to reach the top of the cylinder, or 
the time for all flies to reach the top of the cylinder.  
2.7 Adult Viability studies 
2.7.1  Introduction 
 During metamorphosis the majority of the larval structures undergo 
selective apoptosis as the animal remodels to its adult form. Thus, the pupal 
stage is a developmentally complex life stage and is sensitive to many insults. 
Furthermore, mutants that lack motor strength or coordination often struggle to 
escape from their pupal cases. Therefore the presence of fully developed flies 
dead in their pupal cases is a nonspecific indicator or nervous system 
dysfunction. 
2.7.2  Materials 
Long SS Forceps, watch glass, fluorescent stereoscope, 1X PBS, and 
fresh food vials. 
2.7.3  Methods 
 Wandering third instar larvae are selected and moved to 1X PBS in a 
watch glass. Larvae are sorted based on genotype using a fluorescent 
stereomicroscope. Larvae are moved to a fresh vial at a density of 25 per vial with 
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a minimum n of 125. Larvae are allowed to undergo pupation for 7 days. The adult 
viability of larvae is quantified as the number of empty pupal cases divided by the 
total number of pupal cases.  
2.8 Adult longevity studies 
2.8.1  Introduction  
 Neurodegenerative disease commonly causes a reduction in human 
lifespan. This phenotype is modeled well in Drosophila. Normal lifespan is short 
(~60 days) and can be reduced by many different types of perturbations. 
Neurodegeneration models commonly have decreased lifespan that often 
coincides with the progression of motor phenotypes. The animals can no longer 
move and get stuck in the media, preventing feeding.  
2.8.3 Materials and methods  
 Adult flies are collected within 24 hours of eclosion and aliquoted to fresh 
food at a density of 25 flies per vial. The total number of flies involved in each 
















Chapter 3 Analysis of the FUS in the Drosophila Nervous System 
3.1 INTRODUCTION 
Fused in Sarcoma (FUS), also known as Translocated in Liposarcoma 
(TLS) was originally studied for its role as a proto-oncogene as it has been 
identified as a component of pathological fusion proteins in cancer. FUS protein 
contains 15 exons and is 526 amino acids in length (Iko et al., 2004). It shares 
structural similarities with TDP-43, including its glycine rich region (GRR) and an 
RNA recognition motif (RRM).  Gene sequencing in ALS families identified 16 
missense mutations in FUS (Kwiatkowski et al., 2009; Vance et al., 2009). This 
represents roughly 4% of familial ALS. In autopsy specimens from patients with 
FUS mutations, FUS is redistributed from the nucleus to ubiquitin positive 
cytoplasmic inclusions.  
 FUS is a ubiquitous protein with many implicated functions. FUS is an 
RNA binding protein, which has been shown to affect splicing in vitro both by 
enhancement and inhibition of exon inclusion (Zinszner et al., 1997). This is due 
to its ability to recruit splicing factors of the SR family, including TASR and SC35 
(Yang et al., 1998). The C-terminal domain that is responsible for this recruitment 
is the site where most of the mutations occur. Therefore a logical hypothesis is 
that the mutations affect splicing activity. FUS also has the ability to regulate 
transcription by interaction with general factors like RNA Pol II and TFIID or by 
binding of transcription factors directly such as Spi-1/PU.1, Nuclear factor (NF), 
or TCF/LEF (Gregory et al., 2004; Sato et al., 2005). Additionally, FUS may act 
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along with TDP-43 in microRNA processing, as both proteins were purified as 
part of the large molecular weight Drosha complex.  
  Several possible mechanisms exist to explain the functional 
consequences of FUS mutations in ALS. First, it may be that mutations in FUS 
result in a loss of function. Most of the mutations in FUS reside in the C-terminal 
end of the protein implicated in splicing function (Göransson et al., 2002). 
However, this C-terminal region was also found to contain a non-canonical 
nuclear localization sequence. It was found that mutations disrupt transportin-
mediated nuclear import, suggesting that disease could arise through a depletion 
of nuclear FUS.  
Although many putative functions exist for FUS, evidence is growing to 
support that its role in splicing is relevant to disease. FUS, along with EWSR1 
and TAF15, constitute the FET family of genes that is thought to be involved in 
splicing. TAF15 mutations have also been found in ALS patients (Epstein and 
Chiang, 2011). Recently, one study aimed to identify the targets of the FET family 
proteins and also to detect any potential difference in bindings specificity caused 
by reported mutations in FUS (Xiao et al., 2011). It was determined that as a 
whole this family of proteins binds an overlapping set of mRNAs. Wild-type FUS 
binds a set of ~7,000 targets, 78% of which are bound primarily at intronic 
regions. The specificity of FUS binding within intronic regions is near splicing 
acceptor sites. Mutation in FUS reduced the bound targets to around 5,000 
mRNAs, only 13% of which were bound in intronic regions. Additionally, FUS 
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mutation leads to loss of binding activity on nearly half of the normal targets of 
FUS.   
 Several studies have also suggested a gain of function model for FUS 
mutations in disease. In rats, overexpression of mutant FUS causes progressive 
paralysis and motor neuron degeneration (Huang et al., 2011). Furthermore, 
several studies in yeast showed that FUS is aggregation prone and along with 
TDP-43, contains a prion-like domain, which is responsible for aggregation (Ju et 
al., 2011; Sun et al., 2011). However, in these models, FUS mutation had no 
effect on aggregation or toxicity, further confusing the role of mutations in FUS 
function.  
Homologs of the FUS gene exist throughout the metazoan kingdom. It is 
well-conserved in common laboratory animals like mice, rats, zebrafish, fruit flies, 
and nematodes. Additionally, a comparison of identified homologs to the 
transcript database identifies similar transcripts in over 30 additional species 
including birds, amphibians, and sea urchins.   
The FUS gene is conserved in Drosophila as cabeza (caz). caz is well 
conserved in both structure and function (Stolow and Haynes, 1995). The caz 
gene is located on the X chromosome within a 4.6 kb region encompassing 
seven exons and six introns. caz is transcribed as a single mature 1630 bp RNA 
containing 1200 bp of coding sequence. Caz protein is 54% identical to human 
FUS and displays identical domain organization to FUS [Figure 3.1].  The 
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highest degree of conservation occurs in the zinc finger and RRM domains, and 
most divergence is present in the QGSY region.  
!   
Like FUS and other FET proteins, the putative functions of Caz relate to 
RNA binding. Caz is the sole representative of this family in Drosophila. The RNA 
binding activity of Caz has been documented using UV cross-linking assays 
(Stolow and Haynes 1995). Caz was purified as a complex specific component of 
the Drosophila splicesome (Herold et al., 2009).  Nevertheless, the exact 
functions of Caz are largely unknown.  
Caz protein is expressed ubiquitously throughout development. Caz is 
expressed in all cells in the embryo until after stage 8. By stage 12 of embryonic 
development, expression becomes localized throughout the expanding germ 
Supplementary Figure 1: Drosophila Caz and Human FUS are similar and located in the nucleus.
(A) Alignment of Human FUS/TLS (NP004591) and Drosophila Caz. Identity is indicated by green boxes, 
double and similarity by yellow boxes (B) Caz, FUS and FUS mutants are found in the nucleus. [Left] 
Drosophila motor neuron cell bodies expressing UAS-Caz, UAS-FUS, UAS-FUSR522G and UAS-FUSP525L 
(green), Histone-YFP (red), and cytoplasmic β-galactosidase (blue) driven by the motor neuron driver 
OK319Gal4.   Single channel images of UAS-Caz, UAS-FUS, UAS-FUSR522G and UAS-FUSP525L .All 
transgenic proteins localize to the nucleus of motor neurons. (C) Western blot analysis of Flag-tagged 
FUS, FUSR522G and FUSP525L driven by GMR-GAL4 indicate protein expression levels are identical.
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Figure 3.1. Caz and FUS protein structure. (A) FUS and Caz share domain identical 
organization. (B) The conservation between Caz is high with 54% identity to FUS. 
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band. The germ band derived neuroblasts develop into the embryonic CNS and 
therefore, expression of genes within the germ band layer is the first indicator 
that genes have a possible function in the nervous system. In the larva, 
expression is ubiquitous, including the nervous system, muscle, gut, and imaginal 
disks. Nevertheless, by the adult stage, the expression becomes enriched in the 
head. The origin of the gene name, cabeza stems from the protein’s enrichment 
in adult head extracts. Like FUS, Caz is detected in the nucleus throughout 
development. 
3.2 AIM and OBJECTIVES 
A series of experiments was done to characterize the role of Caz and FUS in the 
Drosophila Nervous System. The linked objectives were as follows:   
3.2.1  To characterize the expression pattern of Caz and FUS  
3.2.2  To create and analyze a caz deletion mutant 
3.2.3 To compare the effects of wild type and mutant Caz and FUS 
overexpression 
3.2.4 To compare the ability of wild type and mutant Caz and FUS to rescue caz 







3.3 EXPERIMENTAL APPROACH 
3.3.1  Characterization of the expression pattern of Caz and FUS   
As noted in section 2.1.3, a construct for caz was generated containing a 
Flag epitope upstream of the caz genomic locus. This was inserted onto the third 
chromosome using phiC31 transgenesis. Animals containing this construct were 
stained using anti-FLAG antibodies during the larval and adult stages.  
To identify the subcellular localization of proteins in vivo all were FLAG-
tagged and co-expressed in larval brain along with UAS-LACZ and UAS-H1-YFP 
using the subset motor neuron driver OK319-GAL4. This includes UAS-FLAG 
constructs for Caz, CazR395G, CazP398L, FUS, FUSR522G, and FUSP525L.  Then, 
larvae were dissected to expose the larval CNS and co-stained with antibodies 
against FLAG, LACZ, and YFP. The preps were then imaged by confocal 
microscopy.  
3.3.2  Generation and analysis of a caz deletion mutant 
A caz deletion mutant was generated by imprecise excision mutagenesis.  
The P-element insertion used to create this line was located in the 5’UTR of the 
neighboring gene, CG32576. Therefore, a genomic rescue construct was 
generated for CG32576 and recombined onto the mutant chromosome. This final 
allele was named caz1.   
Since caz is present on the X chromosome, analysis of caz1 animals was 
done in hemizygous males. The analysis included: adult viability, locomotor 
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behavior, and longevity. All phenotypes were rescued with a Caz-genomic line to 
make sure that they were specific for caz deletion.  
 The structure and function of the NMJs of the caz1 mutant were assessed 
using methods described previously (Brent et al., 2009; Brent et al., 2009). 
3.3.3  Comparison of the effects of overexpression of WT and mutant protein 
The neuronal driver C155-GAL4 was used to drive WT and mutant Caz 
and FUS proteins. These animals were analyzed for defects in adult viability, 
locomotion, and longevity. Expression of Caz or FUS constructs within motor 
neurons was driven by OK6-GAL4. The effect of Caz or FUS overexpression on 
NMJ morphology was measured.  
3.3.4  Rescue of caz1 with wild type and mutant protein 
  The caz1 mutant was recombined with the pan-neuronal driver, C155-
GAL4 to drive expression of Caz and FUS wild type and mutant proteins. The 










3.4 RESULTS and DISCUSSION 
3.4.1 Drosophila FUS Expression Pattern and Localization 
 An epitope tagged caz genomic construct was used to study the 
expression pattern of Caz. In the larva, Caz is detected in all tissues examined 
including the CNS, glia, and muscles [Figure 3.2]. Caz is also detected in the 
adult CNS. Larval brains were co-stained against Caz and also nuclear marker 
ELAV. Caz appears to colocalize with ELAV suggesting that within the larval 
brain Caz and ELAV share the same distribution.  
In mammalian systems, FUS is reported to have a nuclear localization, 
which is disrupted by ALS mutations. In order to verify whether this finding is 
recapitulated in the Drosophila CNS, UAS constructs for Caz and FUS proteins 
were generated. These proteins were then coexpressed with the cytoplasmic 
marker LACZ and histone marker H1-YFP [Figure 3.3]. WT Caz and FUS 








Figure 3.2. Developmental expression pattern of Caz protein. (A) Expression pattern of 
Caz within the larval brain. (B) Adult brain and ventral nerve cord. (C) Higher magnification of 
larval brain showing Caz immunofluorescence. (D) Colocalization of Caz with neuronal nuclear 
marker ELAV. !
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was poor. These findings suggest that the wild-type nuclear localization of FUS is 
conserved in Drosophila motor neurons.  
 
 In order to check the consequences of mutations of FUS on its cellular 
distribution, UAS constructs were generated for ALS associated point mutations 
FUSR522G and FUS P525L. Unlike in mammalian systems, ALS relevant point 
mutations in FUS do not disrupt the nuclear localization of FUS. The conserved 
residues in Drosophila proteins were also mutated to generate CazR395G and 
CazP398L. When expressed in motor neurons, the immunofluorescence of 
CazR395G and Caz P398L is detected outside of the H1-YFP signal in a pattern 
much more closely co-localizing with LacZ [Figure 3.4]. Thus, while disease 
relevant point mutations do not disrupt the cellular localization of mutant FUS  
Supplementary Figure 1: Drosophila Caz and Human FUS are similar and located in the nucleus.
(A) Alignment of Human FUS/TLS (NP004591) and Drosophila Caz. Identity is indicated by green boxes, 
double and similarity by yellow boxes (B) Caz, FUS and FUS mutants are found in the nucleus. [Left] 
Drosophila motor neuron cell bodies expressing UAS-Caz, UAS-FUS, UAS-FUSR522G and UAS-FUSP525L 
(green), Histone-YFP (red), and cytoplasmic β-galactosidase (blue) driven by the motor neuron driver 
OK319Gal4.   Single channel images of UAS-Caz, UAS-FUS, UAS-FUSR522G and UAS-FUSP525L .All 
transgenic proteins localize to the nucleus of motor neurons. (C) Western blot analysis of Flag-tagged 
FUS, FUSR522G and FUSP525L driven by GMR-GAL4 indicate protein expression levels are identical.
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Figure 3.3. Cellular distribution of Caz and FUS proteins. In vivo expression of Caz and 
FUS proteins in a subset of motor neurons using OK319-Gal4. Top row is the distribution of Caz 
and FUS proteins compared with nuclear m rker H1-YFP and cytoplasmic m rker βG l. Bottom 
row is the distribution of Caz and FUS proteins alone. 
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proteins, mutations in Caz cause a nuclear to cytoplasmic shift in protein 
localization.  
3.4.2  Loss of function studies  
 Deletion of the caz gene was accomplished by imprecise excision of the 
EP1564 transposon. The neighboring gene, CG32576, was also deleted. 
Therefore, a rescue construct was recombined onto the mutant chromosome. 
The resulting mutant was named caz1. Though caz1 mutant larvae appeared 
morphologically normal, only 14.0% (P<0.001) completed pupation successfully 
and eclosed to produce viable adults when compared with controls [Figure 3.4]. 
Addition of a single copy of the Caz genomic transgene was enough to fully 
rescue this defect. caz1 mutant adults have a range of non-neuronal phenotypes 
including a mild rough eye defect, abnormal genitalia, and defects in both bristle 
and wing vein organization. These phenotypes are also rescued by the Caz 
genomic construct (Data not shown).  
Upon performing adult locomotion testing, it was discovered that caz1 
mutants have impaired walking behavior. While control animals display long 
Figure 3.4. Cellular distribution of Caz and Caz mutant proteins. In vivo expression of Caz 
and Caz mutant proteins in a subset of motor neurons using OK319-Gal4. (A, C, & E) the 
distribution of Caz and Caz proteins compared with nuclear marker H1-YFP and cytoplasmic 
marker βGal. (B, D, & F) the distribution of Caz and FUS proteins alone. 
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We further observed that caz mutant males had a shorter life 
span than control male flies (Figure 1H). The average life span of 
control males was 53 days, whereas caz mutants lived an average 
of 23 days, a 57% decrease (P < 0.001). The Caz geno ic transgene 
fully restored the average life span of caz mutants to control levels 
(Supplemental Figure 2C), as did neuronal expression of tra sgen-
ic Caz or hFUS (Figure 1H). In contrast, expression of hFUSR522G 
or hFUSP525L in caz mut nts did ot signific ntly restore median 
life span, although maximum life span was increased (Figure 1H). 
Overexpression of Caz or hFUS transgenes in control animals ha  
no effect on longevity (Supplemental Figure 2D). Therefore, as was 
fou for locomotion, fALS mutant FUS pr teins we  deficient 
in an activity required for longevity in Drosophila. We examined the 
brain tissue of 25-day-old caz mutants a d controls for evidence of 
neuronal loss (Supplemental Figure 2E) and did not observe vacu-
olization or ther evidence of ex ensive neuronal death. Interest-
ingly, overexpression of fALS mutant human SOD1 in Drosophila 
can also inhibit locomotion without induc ng neuronal loss (20).
tbph mutants have phenotypes similar to those of caz mutants. The Dro-
sophila homolog of TDP-43, TBPH, is only expressed in neurons 
(15, 16), and protein-null mutants of tbph can survive to adulthood 
(ref. 21 and Supplemental Figure 3G). We examined the phenotype 
of adult transallelic null mutants of tbph to compare them with 
caz mutants. Unlike in caz mutants, we did not observe defects in 
eye, wing, or genital development in adult tbph mutants. When we 
examined the eclosion rate of tbph mutants, we found that only 
19.4% (P < 0.001) of tpbh mutants survived to adulthood compared 
with controls (Figure 2A). This defect was rescued completely by 
expression of either transgenic Drosophila TPBH or human TDP-
43 (hTDP-43) in the neurons of tbph mutants. We also examined 
adult locomotor speed in adult tbph mutants (Figure 2, B and 
C). Compared with controls, tbph mutants had a dramatic 88.4% 
(P < 0.001) reduction of locomotor speed that was also fully res-
cued by neuronal expression of TBPH or hTDP-43. Finally, we 
examined the longevity of these mutants (Figure 2D). We found 
that the marked reduction in the survival of tbph mutants to an 
average of 4 days (P < 0.001) was also restored to control levels by 
neuronal expression of TBPH or hTDP-43. Therefore, consistent 
with previous studies (21), we find that tbph mutants, in compari-
son with caz mutants, have similar, though quantitatively more 
evere, eclosion, adult locomotion, and longevity phenotypes.
caz and tbph are components of a common genetic pathway in 
neurons. To determine whether a genetic relationship existed 
between caz and tbph, we attempted to cross-rescue tbph or caz 
mutants by overexpression of the other gene. First, we expressed 




spurts in continued forward movements with minimal stopping, caz1 mutants 
walked much more slowly and had long periods of unproductive movement. 
Furthermore, caz1 mutants cannot fly, fall to their backs often, and have a difficult 
time getting back upright once fallen. Collectively, these defects result in a 67.6 
% decrease (P<0.001) in locomotor velocity compared to controls. This finding 
was reproduced in a negative geotaxis assay with a 55.9% (P<0.001) relative 
reduction in climbing ability [Figure 3.6]. In either case, defects in locomotor 




































































































































































Figure 3.5. Phenotypes of caz1 mutants. (A) Percentage of male larva of the indicated 
genotypes that eclosed to produce adults (n > 100). (B) Representative image of 10 
superimposed paths of 60 seconds of adult locomotion for control (precise excision) of 1-day-
old adult male flies. (C) Representative image of 10 superimposed paths of 60 seconds of 
adult locomotion of caz1 mutant 1-day-old adult male flies. (D) Representative image of 10 
superimposed paths of 60 seconds of adult locomotion of caz1; Caz genomic 1-day-old adult 
male flies. (E) Walking speed of 1-day-old adult male flies of the indicated genotypes in a 60-
second trial (n > 30). Error bars represent SEM. ***P < 0.001. 
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In addition to defects in viability and locomotion, caz1 mutants live on 
average 57% shorter than controls (P<0.001)[Figure 3.6]. The caz1 mutants lived 
an average of 23 days compared to 53 days for controls. These findings 
suggested that there might be some age dependent neuronal loss. Thus, brain 
sectioning was performed on 25-day-old controls and caz1 mutants. However, 
there was no observable vacuolization or other evidence of extensive neuronal 
death. The NMJ synapses of caz1 mutant larval were examined for any defects in 
synaptic morphology [Figure 3.7].  These studies showed that the caz1 mutants 
had morphologically normal synapses. Quantification of control and caz1 mutant 




























































25 Day aged control 
25 Day aged caz1
A B C
D
Figure 3.6. Phenotypes of caz1 mutants continued. (A) Climbing ability of 1-day-old male 
flies of control (precise excision), caz1 and caz1 mutants with a Caz genomic rescue 
transgene. Task was scored as percentage if animals able to climb 15 cm up a 30 cm tall 
cylinder in 5 minutes. (n>50). (B) Percentage survival of adult male flies of the indicated 
genotypes (n > 100). (C) Eye and brain optic lobe sections from 25 day old precise excision 
control. (D) Eye and brain optic lobe sections from 25 day old caz1 mutant adult males. (C-D 
were performed by Andrew Tomlinson Ph.D.). Error bars represent SEM. ***P < 0.001. 
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3.4.3  Gain of Function Studies 
Deletion of caz has negative consequences on development, locomotor 
behavior and longevity. Tissue specific overexpression was used to ascertain 
whether an alternate gain of function model is possible. The pan-neuronal driver, 
C155-GAL4 was used to drive Caz or FUS expression. Neuronal overexpression 
of Caz or FUS had no effect on the adult viability of wild-type animals [Figure 
3.8]. No significant difference in locomotor speed was detected when Caz, FUS, 
or FUS fALS mutants were overexpressed in neurons alone. Likewise, the 
longevity of wild-type flies was not significantly changed due to neuronal 

































Figure 3.7.  Larval NMJ of caz1 mutants. Third instar NMJ terminals stained with anti-CSP 
(green) to label the presynapse and anti-HRP (red) to label the neuronal membrane at muscle 
4, segment A3 for (A) Controls and (B) caz1 mutants (C) Quantification of synapse terminal 
bouton number divided by muscle surface area for muscle 4 segment A3 normalized to 
control. Error bars represent SEM. 
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 To identify any possible function for Caz or FUS in synaptic development, 
these proteins were overexpressed using the motor neuron driver, OK6-GAL4 
[Figure 3.9 & 3.10]. Overexpression of Caz or FUS proteins in motor neurons 
causes a 35.3 % or 35.2% (P < 0.001) increase in synaptic size. However, motor 
neuron directed expression of FUS fALS mutants, FUSR522G or FUSP525L did not 
significantly alter synaptic size when compared with controls. Thus, while wild 





























































































Figure 3.8. Neuronal overexpression of Caz and FUS proteins. (A) Walking speed of adult 
male flies expressing transgenic Caz, FUS, FUSP525L, and FUSR522G using the pan-neuronal 
driver C155-GAL4 (n>10). (B) Longevity of adult male flies expressing transgenic Caz, FUS, 








OE FUSR522GD E OE FUSP525L
Figure 3.9. NMJ morphology following motor neuron overexpression of Caz and FUS 
proteins. Third instar NMJ terminals stained with anti-CSP (green) to label the presynapse 
and anti-HRP (red) to label the neuronal membrane at muscle 4, segment A3 for               
(A) Controls (B) FUS (C) Caz (D) FUSR522G and (E) FUSP525L.  
Figure 3.10. NMJ morphology following motor neuron overexpression of Caz 
and FUS proteins.  Quantification of synapse terminal bouton number divided by 
muscle surface area for muscle 4 segment A3 normalized to control. Error bars 

















































3.4.4 Rescue of mutant phenotypes 
 caz1 mutants have a number of disease relevant phenotypes including 
defects in adult viability, locomotion and longevity. The neuronal driver, C155-
GAL4 was used to drive the expression of Caz and FUS proteins in the caz1  
mutant background in an attempt to rescue caz1 mutant phenotypes. Neuronal 
restoration of Caz or FUS was sufficient to improve the eclosion percentage of 
caz1 mutants back to control levels [Figure 3.11]. caz1 mutant adult viability was 
also fully rescued by fALS associated mutations, FUSR522G or FUSP525L.  
Neuronal expression of wild-type Caz, while not able to completely rescue 
caz1 mutant locomotion defects, was able to provide an 82% (P < 0.001) increase 
in locomotor speed when compared to controls [Figure 3.12]. However, this was 
still significantly different from controls or rescue with a genomic construct 
suggesting that in addition to neuronal expression of Caz, non-neuronal 
expression is required for proper locomotor behavior. Neuronal rescue with wild 
type human FUS was able to increase locomotor speed by 75% (P < 0.001). This 
result was not significantly different from rescue with transgenic Caz. However, 
neuronal expression of fALS mutant FUSR522G did not provide significant rescue 
of locomotor speed. Additionally, while FUSP525L was able to provide significant 
rescue, these animals were still 23.6% (P < 0.05) slower than rescue with a wild-
type FUS construct. These results reveal that locomotor behavior has a greater 
sensitivity to ALS mutations than that of eclosion. Thus, ALS mutations disrupt a 
function of FUS that is essential for locomotor behavior. 
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 Neuronal expression of Caz was also used to rescue the longevity defect 
of caz1 mutants [Figure 3.12]. Interestingly, neuronal rescue using transgenic 
Caz was able to fully rescue the longevity of caz1 mutants. Likewise, expression 
of transgenic FUS in neurons fully rescued the caz1 mutant longevity defect.  In 
contrast, neuronal rescue using fALS associated FUS mutants, FUSP525L or 
FUSR522G, did not significantly improve median lifespan of caz1 mutants. Thus, 
fALS mutations disrupt an activity of FUS that is important for both locomotion 
and longevity.  
 
 
Figure 3.11. Neuron specific rescue of caz1 mutant eclosion and locomotion defects. 
(A) Percentage of male larva of the indicated genotypes that eclosed to produce adults (n > 
100). (B) Walking speed of 1-day-old adult male flies of the indicated genotypes in a 60-
second trial (n > 30). (A) was performed by Ji-Wu Wang Ph.D. Error bars represent SEM. 












































































































































 This chapter characterized the role of FUS in the Drosophila nervous 
system. The endogenous expression pattern of Caz was found to be ubiquitous, 
with definite expression in the CNS of both the larval and adult fruit fly. Caz was 
found to colocalize with neuronal marker ELAV in the larval CNS, supporting the 
idea that Caz is a nuclear protein. Transgenic lines were used to overexpress 
wild type FUS and Caz showing that they have similar subcellular distributions. 
ALS relevant mutations do not disrupt the nuclear localization of FUS protein. 
However they do cause a cytoplasmic redistribution of Caz protein. These results 
suggest that while WT Caz and FUS share their normal localization, the effects of 
mutations on nuclear import are distinct between species.  
A caz null mutant was generated and analyzed. This mutant was found to 
have defects in adult viability, locomotion, and longevity. All of these phenotypes 
Figure 3.12. Neuron specific rescue of caz1 mutant longevity defect. Percentage 































are rescued by a genomic construct verifying that they are specific to caz 
deletion. Brain and optic lobe sectioning of aged flies did not display any 
noticeable changes suggesting neuronal degeneration. These findings suggest 
that caz1 adult phenotypes are due to progressive neuronal dysfunction rather 
than degeneration.  
Overexpression of Caz and FUS alleles was performed using the UAS-
GAL4 system. Neuronal overexpression of Caz, FUS, and fALS FUS mutations 
did not cause any significant defects in adult viability, locomotor speed, or 
longevity. It was found that overexpression of wild-type Caz and FUS cause NMJ 
synaptic expansion. FUS fALS mutant alleles appear to lack this activity 
suggesting that synaptic expansion is function of FUS that is specifically 
disrupted by ALS mutations.  
Neuron specific rescue of caz1 mutant phenotypes was performed. It was 
found that the adult viability defect of caz1 mutants was rescued by Caz, FUS, 
and fALS mutants rescue equally well. The caz1 adult locomotor phenotype was 
significantly but not fully rescued by wild-type FUS and Caz. Conversely, fALS 
mutants were not able to improve the caz1 mutant locomotion defect. Finally, the 
caz1 mutant longevity defect was fully rescued by wild type Caz and FUS 
expression, but median survival was not improved by expression of fALS 
mutants. These results support a loss of function model in which locomotion and 
longevity but not adult viability are functions of FUS that are specifically disrupted 
by fALS mutations. 
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 Chapter 4 Analysis of TDP-43 in the Drosophila nervous system 
4.1 INTRODUCTION 
TAR DNA-binding protein-43 (TDP-43) was originally discovered and 
named for its ability to bind to the Transactive Response (TAR) element of the 
HIV-1 tat gene (Ou et al., 1995). TDP-43 is a 414 amino acid, 43-kDa protein 
containing two RNA recognition motifs (RRMs) and a C-terminal Glycine-rich 
domain. In 2006, the study of TDP-43 became energized when it was identified 
as a major component of the hallmark ubiquitin inclusions found in FTLD-U and 
ALS (Neumann et al., 2006). This finding provoked several gene-sequencing 
studies that discovered mutations in both familial and sporadic ALS (Van Deerlin 
et al., 2008; Kabashi et al., 2008). TPD-43 is a multifunctional protein with 
implicated roles in diverse cellular processes such as transcription, translation 
and splicing (Ferraiuolo et al., 2011). 
A large focus has centered on understanding the relationships between 
TDP-43 inclusions and disease pathogenesis. The TDP-43 moiety within the 
inclusions is a caspase-3 cleaved fragment that is hyperphosphorylated and 
ubiquitinylated (Neumann et al., 2006). TDP-43 inclusions also appear in other 
neurodegenerative diseases including Inclusion Body Myopathy associated with 
Paget Diseases of Bone and Frontotemporal Dementia (IBMPFD), Perry 
Syndrome, and Parkinsonism Dementia Complex of Guam (Hasegawa et al., 
2007; Weihl et al., 2008; 2008; Farrer et al., 2009; 2009). Inclusions form in 
diverse cell types including glia, motor neurons, hippocampal neurons, and 
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muscle. In the pathological tissues, TDP-43 immunoreactivity is absent from the 
nucleus, indicating that the inclusions may represent a loss of nuclear function of 
TDP-43. This idea was validated by studies in neural cell culture in which the 
nuclear localization signal (NLS) of TDP-43 was deleted (Winton et al., 2008). 
This deletion resulted in the formation of cytoplasmic inclusions that could 
sequester normal full-length protein. In vitro data from yeast and HeLa cells 
suggest that TDP-43 inclusions are toxic to cells which may be the cause of 
degeneration seen in TDP-43 proteinopathy (Johnson et al., 2008). 
 There are more than 30 reported mutations in TDP-43 that localize to its 
C-terminal domain (Buratti, 2009). One hypothesis is that mutations might disrupt 
hnRNP binding and abrogate normal splicing regulatory activity (Buratti et al., 
2005). However, in biochemical assays, hnRNP binding by the C-terminal 
domain and splicing activity were unaffected by mutations in TDP-43 
(D'Ambrogio et al., 2009). Nevertheless, two of the mutations (M337V and 
Q331K) have documented effects on chick neuropore development, including: 
failed limb bud formation, increased apoptosis and developmental delay 
(Sreedharan et al., 2008). In yeast, the aggregation and toxicity phenotypes seen 
in previous studies were significantly enhanced upon expression of mutant alleles 
of TDP-43 (Johnson et al., 2009).  In mice, expression of the A315T allele under 
the control of the prion promoter resulted in neurodegeneration without TDP-43 
redistribution form the nucleus to cytoplasmic inclusions (Wegorzewska et al., 
2009).  
 78 
 Of the proposed roles of TDP-43 in RNA metabolism, evidence is 
accumulating to support splicing as the major function in neurons. Early studies, 
showed that TDP-43 could promote exon inclusion of Spinal Motor Neuron (SMN) 
where it resides in nuclear bodies that associate with other well known nuclear 
bodies such as Cajal bodies, GEM bodies, and Speckle bodies (Wang et al., 
2002; 2002; Shan et al., 2010). Speckle bodies contain the serine arginine 
protein, SC35 that acts as a splicing factor. GEM bodies contain SMN, which is 
important for the minor splicing pathway (Yong et al., 2004; Caceres and Misteli, 
2007). Therefore, by acting as a scaffold between nuclear bodies, TDP-43 may 
function to coordinate splicing. Furthermore, depletion of TDP-43 in neurons 
leads to mis-splicing of a number of TDP-43 mRNA targets (Polymenidou et al., 
2011).  
The Drosophila homologue of TDP-43, TBPH, is remarkably similar to the 
human form (Ayala et al., 2005). It is a 531 amino acid, 58.1 kDa protein. 
Alignment using ClustalW indicates 46% identity between human and Drosophila 
proteins. The highest degree of similarity, 59%, is found in the RRM domains. In 
vitro studies indicate that TBPH has comparable nucleic acid binding specificity 
and splicing regulatory activity.  
Studies of TDP-43 in Drosophila have provided support for both loss of 
function and gain of function disease mechanisms. Deletion of tbph has been 
reported to cause locomotor deficiency, NMJ morphological defects, and 
decreased viability (Feiguin et al., 2009). These phenotypes are completely 
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rescued by motor neuron specific expression of both human and fly genes.  
TBPH has also been shown to play a similar positive role in the regulation of the 
dendritic arborization of sensory cells (Lu et al., 2009). In contrast, 
overexpression of TBPH has been reported to cause motor neuron degeneration, 
as well as RNA dependent defects in locomotion and longevity (Voigt et al., 2010; 
Li et al., 2010).  
4.2 AIM and OBJECTIVES 
A series of experiments were performed to characterize the role of TDP-43 in the 
Drosophila Nervous System. The linked objectives were as follows:   
4.2.1 To analyze a tbph deletion mutant 
4.2.2  To compare the effects of wild type and mutant TBPH and TDP-43 
overexpression 
4.2.3 To compare the ability of wild type TBPH and TDP-43 to rescue TBPH 













4.3 EXPERIMENTAL APPROACH 
4.3.1 Analysis of a tbph deletion mutant 
A TBPH deletion mutant was previously published by Feguin and 
colleagues (Feiguin et al., 2009). We obtained this tbphΔ23 mutant and found in 
preliminary experiments that this mutant was homozygous lethal during the pupal 
stage even though it had previously been analyzed in a homozygous genotype 
(Feiguin et al., 2009). Therefore, all our work was done in a trans-allelic 
combination with Df(2R)BSC660 B# 26512, which was viable. The resulting 
genotype was named tbph-/-. The analysis included: adult viability, locomotor 
behavior, and longevity. 
4.3.2 Comparison of the effects of overexpression of WT and mutant protein 
The neuronal driver C155-GAL4 was used to drive WT TBPH or TDP-43 
proteins. The resulting animals were analyzed for defects in adult viability, 
locomotion, and longevity. Specific expression of TBPH or TDP-43 constructs in 
motor neurons was driven by OK-GAL4. The effect of TBPH or TDP-43 
overexpression on NMJ morphology was measured.  
4.3.3 Rescue of the TBPH deletion mutant with WT Drosophila and Human 
Proteins 
The ability TBPH and TDP-43 proteins to rescue tbph-/- phenotypes was 
measured. The analysis included: adult viability, locomotor behavior, and 
longevity. The neuronal subtype required for larval locomotion was analyzed 
using tissue-specific expression in motor neurons or sensory/interneurons.  
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4.4 RESULTS and DISCUSSION 
4.4.1 Loss of Function Studies 
 The tbphΔ23 mutant used in these studies is a null allele of tbph (Feiguin et 
al., 2009). This mutant contains deletion of the first 1.6 kb of the tbph genomic 
locus containing its first two exons.  Biochemical analysis was used to verify that 
the tbphΔ23 mutant is indeed protein null (data not shown). Animals homozygous 
for the tbphΔ23 allele live to the larval stage but do not survive pupation. However, 
when analyzed in transallelic combination with Df(2R)BSC660, a small number of 
larvae survive into adulthood. tbph mutant larvae are observably slower than 
controls with a 48.3% (P<0.001) decrease in locomotor speed compared to wild 
type larvae [Figure 4.6]. Examination of the adult viability of tbph mutants 
revealed that very few, just 18.4%(P<0.001) of these animals survived into 
adulthood [Figure 4.1].  
 tbph mutant adults are morphologically normal with no observed defects 
in eye, genital, or wing development. However, tbph mutant adults possess an 
observable gait disturbance in which animals appear to lack strength most 
severely in the forelimb and as a result use middle limbs as forelimbs. Thus, they 
possessed both widened gait and also a noticeable tripping phenotype in which 
the animal tripped over its forelimbs while walking. Compared with controls, tbph 
mutants had an 88.4% (P<0.001) decrease in adult locomotor speed [Figure 
4.1]. Furthermore, longevity of tbph mutants was markedly decreased with an 
average of only 4 days (P<0.001). Additionally, although homozygous tbph 
 82 
mutants were reported to have a larval NMJ size reduction (Feiguin et al., 2009), 





























































































































































Figure 4.2 Larval NMJ of tbph-/- mutants. Third instar NMJ terminals stained with anti-CSP 
(green) to label the presynapse and anti-HRP (red) to label the neuronal membrane at muscle 
4, segment A3 for (A) controls and (B) tbph-/- mutants. (C) Quantification of synapse terminal 
bouton number divided by muscle surface area for muscle 4 segment A3 normalized to 
control. Error bars represent SEM. 
Figure 4.1 Phenotypes of tbph-/- mutants. (A) Percentage of male larva of the indicated 
genotypes that eclosed to produce adults (n > 100). (B) Representative image of 10 
superimposed paths of 60 seconds of adult locomotion for control of 1-day-old adult male 
flies (C) Representative image of 10 superimposed paths of 60 seconds of adult locomotion 
of tbph-/- mutant 1-day-old adult male flies. (D) Walking speed of 1-day-old adult male flies 
of the indicated genotypes in a 60-second trial (n > 30). (E) Percentage survival of adult 































4.4.3 Gain of Function Studies  
 TBPH or TDP-43 was overexpressed in a WT background to test for any 
gain of function phenotypes. For these experiments, the pan-neuronal driver 
C155-GAL4 was used to drive transgenic TBPH or TDP-43. Neuronal 
overexpression of TBPH or TDP-43 resulted in no significant change in adult 
viability, locomotor speed, or lifespan [Figure 4.3].  
 To identify any potential functions in synaptogenesis, transgenic TBPH 
and TDP-43 were overexpressed using the motor neuron driver, OK6-GAL4. 
Motor-neuron expression of TBPH results in a large, 68.4% (P<0.001), increase 
in synaptic size [Figure 4.4].  Similarly, when this experiment was done with 
TDP-43, synaptic size was increased by 65.5% (P<0.001). However, expression 






















































































Figure 4.3 Neuronal overexpression of TBPH and TDP-43 proteins. (A) Percentage of 
male larva that eclosed to produce adults while expressing TBPH or TDP-43 using the pan-
neuronal driver C155-G4 (n > 100). (B) Walking speed of adult male flies expressing 
transgenic TBPH and TDP-43 using the pan-neuronal driver C155- GAL4 (n>10). (C) 
Longevity of adult male flies expressing TBPH and TDP-43 using the pan-neuronal driver 




4.4.4 Rescue of Mutant Phenotypes  
 In earlier studies, it was identified that the tbph deletion mutant had 
defects in adult viability, locomotion, and longevity. Neuronal expression of TBPH 
fully rescues these defects [Figure 4.5]. Likewise, TDP-43 driven by the pan-
neuronal driver C155-GAL4 was able to restore the viability, locomotion, and 
longevity phenotypes to levels not significantly different from controls. 
Additionally, experiments were performed to rescue the larval locomotor 
phenotype of tbph mutants [Figure 4.6]. To investigate the neuronal subtype that 
is the site of action of TDP-43, TDP-43 was expressed in all neurons, motor 
neurons only, or in sensory/interneurons only. As in the adult, pan-neuronal 
expression of TDP-43 using C155-GAL4 was sufficient for full rescue of the tbph 
mutant crawling behavior. Expression of TDP-43 in motor neurons using D42-

























































Figure 4.4 NMJ morphology following motor neuron overexpression of TBPH and TDP-43 
proteins. Third instar NMJ terminals stained with anti-CSP (green) to label the presynapse and 
anti-HRP (red) to label the neuronal membrane at muscle 4, segment A3.Transgenes were 
expressed in motor neurons using OK6-GAL4. (A) Controls and (B) TBPH (C) TDP-43 (D) TDP-
43M337V. (E) Quantification of synapse terminal bouton number divided by muscle surface area 
for muscle 4 segment A3 normalized to control. Error bars represent SEM. ***P < 0.001. 
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Expression of TDP-43 or in sensory/interneurons with CHA-GAL4 did not 























































































































Figure 4.5 Neuron specific rescue of tbph mutant eclosion and locomotion defects.    
(A) Percentage of male larva of the indicated genotypes that eclosed to produce adults (n > 
100). (B) Walking speed of 1-day-old adult male flies of the indicated genotypes in a 60-
second trial (n > 30). (C) Percentage survival of adult male flies of the indicated genotypes.  
(A) was performed by Ji-Wu Wang Ph.D. Error bars represent SEM. *P < 0.05; ***P < 0.001. 
Figure 4.6 Tissue-specific rescue of tbph mutant larval locomotion defect.            
(A-B) Representative images of 10 superimposed paths of 60 seconds of locomotion for 
(A) control and (B) tbph-/- larvae. (C) Normalized path length for larvae of the indicated 









































































































 This chapter characterized the role of TDP-43 in the Drosophila nervous 
system. The tbph-/- mutant was analyzed with the identical techniques used to 
analyze the caz1 mutant in Chapter 3. Like caz1 mutants, tbph-/-  mutant had 
defects in adult viability, locomotion, and longevity. Although it was previously 
reported that tbph mutants possessed defects in NMJ synaptogenesis (Feiguin et 
al. 2009), this finding could not be reproduced in transallelic combinations. One 
distinction between the locomotor phenotypes of caz1 and tbph-/- mutants is that 
the tbph-/- phenotype is more severe and begins during the larval stage. In 
contrast, caz1 mutant larvae possess normal larval crawling speed suggesting 
that they possess an increased maternal component or that Caz simply plays a 
greater role in adult locomotion. The mechanism behind this distinction is 
unclear.  
 Overexpression studies were used to identify any potential gain of function 
phenotypes caused by TBPH or TDP-43. Overexpression of TBPH, but not TDP-
43 in all tissues is larval lethal.  However, overexpression in all neurons using 
C155-GAL4 produced no alterations in adult viability, locomotion, or longevity. 
When TBPH or TDP-43 was overexpressed in motor neurons using OK6-GAL4 
caused a large increase in NMJ synaptic size. However, when a fALS mutant 
protein, TDP-43M337V, was overexpressed in motor neurons no significant 
increase in synaptic size was detected. These findings suggest that NMJ 
overgrowth is a gain-of-function phenotype that is suppressed by fALS.  
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 tbph mutants were found to have defects in viability, locomotion, and 
longevity. Rescue experiments were performed using neuronal expression of 
TBPH or TDP-43. It was found that TBPH and TDP-43 rescue tbph mutant 
phenotypes equally well. This result suggests that human TDP-43 can 
functionally substitute for TBPH in vivo.  Tissue specific replacement of the TDP-
43 protein in tbph mutant larvae was used to further analyze the cell types that 
require normal TDP-43 function for normal locomotion. Expression in all neurons 
or in just motor neurons can fully rescue the locomotion phenotype of tbph 
mutant larvae. Alternatively, expression of TDP-43 in only sensory/interneurons 
of tbph mutants did not improve larval crawling behavior suggesting that the site 





Chapter 5 Analysis of the interactions between FUS and TDP-43  
5.1 INTRODUCTION 
In recent years, a total of 16 genes have been associated with ALS, and 
this number is growing steadily (Andersen and Al-Chalabi, 2011). These genes 
are involved in diverse cellular pathways such as protein degradation, vesicle 
trafficking, cell signaling, and RNA metabolism.  Several genes are now present 
in each of these functional classes. The study of each one of these genes will 
undoubtedly yield vital information moving the field closer to the development of 
viable therapeutics. Nevertheless, an increasingly attractive idea is that rather 
than acting independently, ALS genes may actually function within the same 
pathways. This circumstance would simplify the molecular understanding of the 
disease and enhance the focus of further study by providing a narrower collection 
of disease relevant pathways. 
With the discovery of the role of TDP-43 in ALS came a renewed vigor to 
the study of motor neuron disease. TDP-43 mutations have been found in both 
fALS and sALS. Furthermore, TDP-43 pathology is a feature present in a high 
percentage of ALS patients and also other neurodegenerative diseases. The 
importance of TDP-43 led ALS investigators to prioritize their gene sequencing 
studies to genes that possess RNA binding activities. This led to the identification 
of mutations in FUS/TLS in fALS.  
Since the discovery of TDP-43 and later FUS, it was clear that these 
proteins have a number of features that make them attractive targets for the 
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study of the genetic circuitry of ALS. Firstly, these genes contain structural 
similarities suggesting that they may function in related pathways [Figure 5.1]. 
Both proteins contain RNA recognition motif (RRM) domains and glycine rich 
regions. Additionally, disease related mutations accumulate in the C-terminus of 
both proteins. The C-terminal domain of TDP-43 is the glycine rich region (GRR), 
whereas this region of FUS has been shown to contain a non-canonical nuclear 
localization signal (NLS). FUS/TLS also has a second concentration of mutations 
in its GRR.  
 
 
 In addition to structural similaritiesTDP-43 and FUS share many of the 
same implicated functions. FUS and TDP-43 may participate in microRNA 
processing, as both proteins were purified as part of the large molecular weight 
Drosha complex. TDP-43 apparently localizes to mRNA transcription and 
processing sites in mammalian neurons (Casafont et al., 2009). It was originally 
proposed to be a transcriptional repressor of the tat gene of HIV-1 and later was 
shown to target the testis specific acrv1 gene (Ou et al., 1995; Lalmansingh et 
al., 2011). FUS also has the ability to regulate transcription by interaction with 
RRM1 RRM2 Glycine-rich region
NLS NES






Figure 5.1 TDP-43 and FUS/TLS share structural features. TDP-43 is a 414 amino 
acid containing protein. Its domains include a nuclear localization sequence (NLS), 
nuclear export signal (NES), 2 RRMs, and a C-terminal glycine rich region (GRR). FUS  
also contains an RRM and GRR. Additionally, FUS contains an N-terminal QGSY-rich 
region, 2 RGG rich regions, and a zinc finger motif.  
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general factors like RNA Pol II and TFIID or by directly binding of transcription 
factors such as Spi-1/PU.1, Nuclear Factor, or TCF/LEF (Hallier et al., 1998; Sato 
et al., 2005). Additionally, both proteins have been shown to engage in nucleo-
cytoplasmic shuttling.   
 Of the implicated functions of TDP-43 and FUS, evidence is most rapidly 
accumulating regarding splicing.  Both proteins possess splicing activity and 
interact with SR family splicing factors such as SC35 (Yang et al., 1998; Mercado 
et al., 2005). Recently, several studies using cross-linking and 
immunoprecipitation (CLIP) were published showing that these proteins bind a 
large number of cellular mRNAs (Tollervey et al., 2011; Polymenidou et al., 2011; 
Hoell et al., 2011).  Both TDP-43 and FUS show a preference in binding to 
intronic regions near splice sites. FUS fALS mutations have been reported to 
decrease the number of FUS targets recognized by nearly 50% suggesting this is 
a disease relevant function. Furthermore, TDP-43 targets have been shown to be 
mis-spliced in ALS patient spinal cord samples (Xiao et al., 2011). 
 In both cellular and in vivo models TDP-43 and FUS have been shown to 
cause similar phenotypes.  Overexpression models have detected negative 
phenotypes such as the formation of protein inclusions and neuronal death 
(Wegorzewska et al., 2009; Huang et al., 2011). Moreover, co-overexpression of 
TDP-43 and FUS in Drosophila were reported to synergize in the promotion of 
neurodegeneration (Lanson et al., 2011).  
 The preliminary chapters in this work, loss of function models of TDP-43 
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and FUS were studied in Drosophila. These models had similar phenotypes 
including a decrease in adult viability, locomotion, and longevity. Furthermore, 
overexpression of TDP-43 and FUS in Drosophila motor neurons was shown to 
cause an expansion of synaptic size. In this chapter, these phenotypes were 
used to analyze the genetic relationships between TDP-43 and FUS in the 
Drosophila nervous system.  
5.2 AIM and OBJECTIVES 
A series of experiments were performed to analyze the genetic relationships 
between FUS and TDP-43 in the Drosophila Nervous System. The linked 
objectives were as follows:   
5.2.1 To compare the ability of TBPH and Caz to modify the phenotypes of caz1 
and tbph-/-mutants 
5.2.2  To compare the ability of caz1 and tbph-/- mutants to modify Caz and TBPH 
overexpression phenotypes at the NMJ 









5.3 EXPERIMENTAL APPROACH  
5.3.1 Cross-rescue of caz1 and tbph-/- mutant phenotypes  
 In previous chapters, I have described a series of experiments that were 
done to analyze the developmental and functional consequences of tbph and caz 
gene deletions. These experiments identified defects that caz1 and tbph-/- have in 
common. Both genes are required for normal adult viability, locomotion, and 
longevity. To identify the genetic relationships between caz and tbph genes, 
cross-rescue experiments were performed. The phenotypes of both mutants are 
significantly improved by expression of their respective WT genes in neurons. 
Therefore, transgenic Caz was expressed in neurons of tbph-/- mutants using the 
pan-neuronal driver, C155-GAL4. Similarly, transgenic TBPH was expressed in 
the neurons of caz1 mutants.  These animals were tested for any modification of 
tbph-/- or caz1 mutant phenotypes.  
5.3.2 Epistasis experiments using Caz and TBPH at the Drosophila NMJ 
Overexpression of Caz and TBPH were demonstrated to cause an 
overgrowth phenotype at the Drosophila larval NMJ. Furthermore human 
homologs of these proteins were shown to elicit an equivalent effect. To test 
whether synaptic expansion caused by TBPH requires the presence of Caz, 
transgenic TBPH was expressed in the motor neurons of caz1 mutants. In 
addition, a requirement of TBPH for NMJ expansion caused by Caz was tested 
by expression of Caz in tbph-/- mutants. 
5.3.3  Biochemical studies of TDP-43 and FUS interactions 
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 Since FUS and TDP-43 might act in the same pathway, it may be possible 
for them to interact by binding to one another. This hypothesis was tested by 
standard co-immunoprecipitation procedures. Also, TDP-43 and FUS binding 
may not be direct and they may instead both be part of a ribonucleoprotein 
complex. Therefore, FUS and TDP-43 interaction may depend on the presence of 
RNA. To test this model, the effect RNase digestion on the physical interactions 
between TDP-43 and FUS was tested. Expression of genomic FLAG-tagged Caz 
in a TBPH mutant was used to test the requirement of TBPH for the maintenance 
of Caz levels. Similarly, the levels of TBPH were measured in caz mutants using 














5.4 RESULTS and DISCUSSION 
5.4.1 Cross-rescue experiments 
 Deletion of either tbph or caz results in a number of negative phenotypes 
that are significantly improved by neuronal replacement of their respective 
proteins (see Chapters 3 and 4). To test the genetic relationships between caz 
and tbph, cross-rescue experiments were performed [Figure 5.2]. First, 
transgenic TBPH was overexpressed in the neurons of caz mutants and its 
effects on the eclosion rates were measured. No significant improvement was 
observed in any of these measures when compared with caz mutants alone. In 
contrast, overexpression of Caz in tbph mutants restored their eclosion rates to 
WT levels.              
                      
Figure 5.2 Cross rescue of the adult viability defect of tbph and caz mutants. 
Percentage of male larva of the indicated genotypes that eclosed to produce adults (n > 100).  
The tbph -/- genotype is tbph Δ23/Df[2R] BSC660. + indicates neuronal expression of UAS-
TBPH, UAS-TDP-43, or UAS-Caz with C155-GAL4. This experiment was performed by Ji-Wu 














































 Cross-rescue experiments were performed using the adult locomotor 
phenotypes of tbph and caz mutants [Figure 5.3]. Overexpression of TBPH in 
caz mutants did not provide any alteration in their locomotor speed [Figure 5.4]. 
However, overexpression of Caz in the neurons of tbph mutants resulted in a 
striking improvement in locomotor behavior. There was a noticeable improvement 
in gait, both in the strength and coordination of movement. The locomotor speed 
was increased by 229.8% (P<0.001) compared with tbph mutants alone, 
although this locomotor speed had still not reached wild-type levels.  tbph 
mutants cannot climb and therefore their performance exceeded the 
experimental time limit in negative geotaxis assays. Neuronal expression of Caz 
in tbph improved climbing ability greatly with many animals able to complete the 
Figure 5.3 Cross-rescue of the locomotor phenotype of tbph and caz mutants 
Representative image of 10 superimposed paths of 60 seconds of adult locomotion for 1-day-
old adult male flies. The genotypes were control, tbph mutant or caz mutants either alone or 






















































task. Compared to tbph mutants, animals rescued with Caz had a 58.8% 
improvement in climbing ability (data not shown).   
 
 Both tbph and caz mutants have severely reduced lifespans. In adult 
viability and locomotion experiments, TBPH expression had no effect on the 
lifespan of caz mutants. In contrast, Caz overexpression in tbph mutants 
increased their survival from an average of five days to levels not significantly 

















































Figure 5.4 Cross-rescue of the locomotor phenotype of tbph and caz mutants 
continued Walking speed of 1- day-old adult male flies in a 60-second trial (n>30). Error 
bars represent SEM. ***P < 0.001. 
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5.4.3  Epistasis analysis of NMJ phenotypes 
 Deletion of either caz or tbph has no effect on the synaptic morphology of 
WT animals. However, overexpression of Caz or TBPH in motor neurons can 
cause synaptic overgrowth phenotypes at the larval NMJ [Fig. 5.6-5.7]. Caz 
overexpression causes a 35.3% (P < 0.001) increase in synaptic size when 
compared to control. TBPH overexpression causes a larger, 68.4% (P < 0.001) 
increase in synaptic size. If Caz and TBPH overgrowth phenotypes are 
dependent on activation of the same cellular pathways, it is possible that their 
activities require the presence of one another. To test this hypothesis, TBPH was 
overexpressed in the caz1 deletion mutant. This resulted in a complete 































Figure 5.5 Neuron specific rescue of caz and tbph mutant longevity defect. Percentage 
survival of adult male flies of the indicated genotypes (n > 68).  
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does not significantly modify the synaptic expansion phenotype caused by Caz 




Figure 5.6  Epistasis of caz and tbph genes at the Drosophila larval NMJ.           
(A-E) Third instar NMJ terminals stained with anti-CSP(green) to label the presynapse 
and anti-HRP(red) to label the neuronal membrane at muscle 4, segment A3 for motor 
neuron overexpressing(OE) transgenic TBPH or Caz either alone or in tbph-/- and caz1 
mutants. (N>30). 
Figure 5.7 Epistasis of caz and tbph genes at the Drosophila larval NMJ. 
Quantification of synapse terminal bouton number divided by muscle surface area for 





























































5.4.5 Biochemical Experiments  
Human FUS and TDP-43 have previously been reported to interact 
physically in mammalian cells (Ling et al., 2010; Kim et al., 2010). To test 
whether this relationship is evolutionarily conserved, co-immunoprecipitation 
experiments were performed on Drosophila adult head extracts. Transgenic Flag-
tagged Caz and YFP-tagged TBPH were generated for this purpose. These 




When Caz is immunoprecipitated with anti-Flag antibody, TBPH can be 
identified in the immunoprecipitate using anti-YFP antibodies [Figure 5.8]. This 
finding suggests a physical interaction between TBPH and Caz proteins in vivo. 
TDP-43 and FUS are both RNA binding proteins and may be interacting as part 
of a ribonucleoprotein complex. To test this hypothesis, co-immunoprecipitation 
was performed on samples that had been treated with RNase. When this was 
Figure 5.8 Biochemical Analysis of Caz and TBPH interactions.                                 
(A) Coimmunoprecipitation of YFP-tagged TBPH with Flag-tagged Caz following 
coexpression of the transgenic proteins in neurons using C155-GAL4. RNase digestion 
largely disrupts this interaction. (B) Immunoblot of endogenous TBPH in caz1 mutants and 
Genomic Flag-tagged Caz levels in tbph-/- mutants. Levels of both proteins were 
unchanged when compared to controls.  
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We further observed that caz mutant males had a shorter life 
span than control male flies (Figure 1H). The average life span of 
control males was 53 days, whereas caz mutants lived an average 
of 23 days, a 57% decrease (P < 0.001). The Caz genomic transgene 
fully restored the average life span of caz mutants to control levels 
(Supplemental Figure 2C), as did neuronal expression of transgen-
ic Caz or hFUS (Figure 1H). In contrast, expression of hFUSR522G 
or hFUSP525L in caz mutants did not significantly restore median 
life span, although maximum life span was increased (Figure 1H). 
Overexpression of Caz or hFUS transgenes in control animals had 
no effect on longevity (Supplemental Figure 2D). Therefore, as was 
found for locomotion, fALS mutant FUS proteins were deficient 
in an activity required for longevity in Drosophila. We examined the 
brain tissue of 25-day-old caz mutants and controls for evidence of 
neuronal loss (Supplemental Figure 2E) and did not observe vacu-
olization or other evidence of extensive neuronal death. Interest-
ingly, overexpression of fALS mutant human SOD1 in Drosophila 
can also inhibit locomotion without inducing neuronal loss (20).
tbph mutants have phenotypes similar to those of caz mutants. The Dro-
sophila homolog of TDP-43, TBPH, is only expressed in neurons 
(15, 16), and protein-null mutants of tbph can survive to adulthood 
(ref. 21 and Supplemental Figure 3G). We examined the phenotype 
of adult transallelic null mutants of tbph to compare them with 
caz mutants. Unlike in caz mutants, we did not observe defects in 
eye, wing, or genital development in adult tbph mutants. When we 
examined the eclosion rate of tbph mutants, we found that only 
19.4% (P < 0.001) of tpbh mutants survived to adulthood compared 
with controls (Figure 2A). This defect was rescued completely by 
expression of either transgenic Drosophila TPBH or human TDP-
43 (hTDP-43) in the neurons of tbph mutants. We also examined 
adult locomotor speed in adult tbph mutants (Figure 2, B and 
C). Compared with controls, tbph mutants had a dramatic 88.4% 
(P < 0.001) reduction of locomotor speed that was also fully res-
cued by neuronal expression of TBPH or hTDP-43. Finally, we 
examined the longevity of these mutants (Figure 2D). We found 
that the marked reduction in the survival of tbph mutants to an 
average of 4 days (P < 0.001) was also restored to control levels by 
neuronal expression of TBPH or hTDP-43. Therefore, consistent 
with previous studies (21), we find that tbph mutants, in compari-
son with caz mutants, have similar, though quantitatively more 
severe, eclosion, adult locomotion, and longevity phenotypes.
caz and tbph are components of a common genetic pathway in 
neurons. To determine whether a genetic relationship existed 
between caz and tbph, we attempted to cross-rescue tbph or caz 
mutants by overexpression of the other gene. First, we expressed 
transgenic TPBH in the nervous system of caz mutants and 
β
A
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done, the amount of coimmunoprecipitation of TBPH by Caz was greatly 
reduced.  
To further understand the relationships between TBPH and Caz function, 
the requirement of TBPH or Caz for the normal expression or stability of the other 
protein was tested. An anti-TBPH antibody was used to immunoblot endogenous 
TBPH in the caz1 mutant. Likewise, the transgenic Flag-tagged genomic Caz line 
was used to monitor the levels of Caz in the tbph-/- mutant [Fig. 5.8]. These 
experiments showed that neither TBPH or Caz were required for the 
maintenance of normal levels of the other protein.  
5.5 CONCLUSIONS 
In order to study the genetic relationships between FUS and TDP-43, a 
series of epistasis experiments were performed using deletion mutants of their fly 
homologs. These mutants share several disease relevant phenotypes including 
defects in adult viability, locomotion, and longevity. Caz and TBPH were 
overexpressed in tbph and caz mutants to determine if one gene could 
supplement for loss of the other gene. Overexpression of TBPH did not 
significantly improve any of the defects caused by loss of the caz gene. However, 
neuronal overexpression of Caz in the tbph null mutants dramatically improved 
their defects in adult viability, locomotion, and longevity.  
To further define the interaction between TDP-43 and FUS in Drosophila, 
epistasis experiments were performed using their NMJ gain of function 
phenotypes. Deletion of tbph had no effect on the synaptic overgrowth phenotype 
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caused by Caz expression. However, when TBPH was overexpressed in the caz1 
mutant background, this phenotype is completely suppressed.   
These results suggest that TDP-43 and FUS act in a pathway that is 
required for the normal development, function, and maintenance of the 
Drosophila nervous system. Increasing Caz can restore the activity of this 
pathway in a tbph mutant while TBPH supplementation cannot alter it in a caz 
mutant. Deletion of caz or tbph in a WT background does not alter the size of the 
Drosophila larval NMJ suggesting that these genes and also the pathways in 
which they act are not required for the normal development or maintenance of 
proper NMJ morphology. However, since overexpression of these proteins 
increases NMJ size, TDP-43 and FUS both function in motor neurons and can 
act on substrates that promote synaptic growth. Furthermore, in gain of function 
experiments, the overexpression phenotype of Caz is unaltered by tbph deletion 
while deletion of caz can fully suppress the synaptic expansion caused by TBPH. 
This suggests that TBPH requires the presence of Caz to access the cellular 
pathways that promote synaptic overgrowth. Thus, Caz and TBPH function in the 
same pathway in Drosophila neurons and Caz is downstream of TBPH in this 
relationship. 
FUS and TDP-43 proteins have been reported to interact in mammalian 
cells. This interaction was tested in the Drosophila brain using co-
immunoprecipitation experiments. Epitope tagged transgenic Caz and TBPH 
were co-expressed in neurons using a pan-neuronal GAL4 driver. When Caz was 
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coimmunoprecipitated, a strong TBPH signal was detected on the immunoblot 
suggesting that the two proteins physically interact in vivo. Furthermore, this 
interaction is largely disrupted by RNase digestion. Therefore, the physical 
interactions between TBPH and Caz may not be direct but rather as part of a 
ribonucleoprotein complex.  
!
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Chapter 6 General Discussion and Future Directions  
The defining goal of all of science has been to connect what we are able 
to see with what lies beneath. In medical science, the greats of the eighteenth 
century utilized the study of morbid anatomy to identify the characteristic brain 
lesions that underlie a number of neurodegenerative diseases. Connecting these 
diseases with genetic mechanisms has been the task of modern biomedicine. 
These studies have been successful in identifying a growing number of genes 
whose dysfunction collectively cause ALS. The evidence supporting interplay 
between these genes is accumulating. Thus, the focus in ALS research has been 
expanded from the study of individual ALS genes to the diagramming of ALS 
gene networks.  
Thus far a number of ALS genes have been shown to act as modifiers of 
TDP-43 dysfunction. VCP mutations lead to the cytoplasmic mislocalization of 
TDP-43, which is required for VCP mediated toxicity (Gitcho et al., 2009; Ritson 
et al., 2010; Shaw, 2010). ATX2 polyQ repeat expansions enhance multiple TDP-
43 overexpression models (Elden et al., 2010). Dynactin mutation results in the 
development of TDP-43 inclusions in Perry syndrome (Farrer et al., 2009). 
Including the work in this thesis FUS has been demonstrated as an interactor of 
TDP-43 both in overexpression and now in loss of function models of disease 
(Lanson et al., 2011; Kabashi et al., 2011; Wang et al., 2011). Therefore, TDP-43 
is being distinguished as a putative node in the genetic circuitry of ALS. The 
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tasks now are the interrogation of further interactions between ALS genes and 
the connection of these genes with specific cellular pathways.  
The work in this thesis outlines a model for FUS and TDP-43 function in 
Drosophila. In this model, TDP-43 and FUS function in a cellular pathway 
involved in adult viability, locomotion, and longevity. In cross-rescue experiments, 
Caz expression can rescue most of the negative phenotypes of tbph deletion 
mutants. Furthermore, caz deletion can suppress TDP-43 overexpression 
phenotypes at the Drosophila NMJ suggesting that TDP-43 requires the 
presence of Caz for its synaptic activity. In contrast, TBPH expression has no 
ability to rescue the phenotypes identified in the caz1 deletion mutant. tbph 
deletion does not modify Caz overexpression phenotypes at the NMJ. The 
unidirectional ability of Caz both in the cross-rescue of tbph null mutants and in 
the modification of TBPH mediated NMJ expansion defines an epistasis 
relationship in which TBPH is genetically upstream of Caz.  
In biochemical experiments, TBPH and Caz were shown to physically 
interact with one another. In addition, this interaction was shown to be highly 
dependent on the presence of RNA. These findings suggest a model whereby 
Caz coordinates with TBPH to bind a collection of cellular RNAs as part of a 
ribonucleoprotein complex. The steps in the assembly of this ribonucleoprotein 
complex are unclear. While RNA binding has been shown to be required for TDP-
43 toxicity models, the work in this thesis still has not shown that RNA binding is 
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the required function of these proteins which is responsible for null mutant 
phenotypes (Voigt et al., 2010). 
 Several experiments that could be done to interrogate this include 
attempting rescue of tbph and caz mutants by proteins containing mutations that 
abolish RNA binding. The same experiment could be applied to the cross-rescue 
of tbph mutants by Caz. In addition, it would be helpful to use biochemical 
experiments to define the domains required for TBPH and Caz to bind each 
other. One could then assess the ability of TBPH and Caz to perform in rescue or 
NMJ overexpression experiments. Furthermore, biochemical experiments could 
be used to define how important the binding of these proteins to each other is 
important for their binding to RNAs.  
Both TBPH and Caz mutants are morphologically normal during the larval 
stage but many do not successfully complete pupation. As noted earlier this is a 
developmentally sensitive time during which many larval tissues including the 
nervous system undergo apoptosis and are replaced in the generation of the 
adult. The finding that this phenotype is rescued fully by replacement of these 
genes only in neurons suggests that the nervous system is developmentally 
perturbed and that only a small percentage of the mutants can survive this insult. 
In addition, the locomotor phenotype is present at day one post-eclosion. 
Therefore, it is likely that there is a developmental defect that contributes to the 
caz and tbph mutant phenotypes identified in these studies.  
 In future work it would be highly informative to confirm a developmental 
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role for caz and tbph through the use of neuronal geneswitch experiments 
(Osterwalder et al., 2001). In this manipulation, neuronal expression of the 
desired gene is turned on under the control of a chemical, RU 486, which is fed 
to flies. In this way Caz or TBPH could be expressed in the adult to assess the 
extent to which this can compensate for their absence during the earlier stages. 
These experiments would also inform therapy because if ALS is indeed caused 
by a loss of function of TDP-43 or FUS, then the ability to intervene in disease by 
activating downstream pathways in spite of any developmental abnormalities is 
vital.  
 It should be noted that the Caz is the sole conserved member of the FET 
family of RNA binding proteins. FUS was only the first of these to be identified as 
mutated in ALS. Recently, TAF15 mutations were also identified in ALS families 
(Epstein and Chiang, 2011). It remains to be seen if the TAF15 targets that are 
misregulated in ALS are identical to those misregulated by FUS. Furthermore, 
since the caz1 mutant generated in this work was used to analyze the function of 
only FUS in Drosophila, in future work it would be highly useful to attempt cross-
species rescue of the caz1 mutant with human TAF15 or EWSR1. These 
experiments would discern whether caz studies are generalizable for all FET 
family members or they are more applicable to FUS alone.   
 Including this study, four studies in total have proposed a model whereby 
TDP-43 and FUS function together in an important but currently unidentified 
pathway in neurons (Kim et al., 2010; Lanson et al., 2011; Kabashi et al., 2011; 
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Wang et al., 2011). Several paths exist to the identification of this pathway, 
however with the accumulating evidence regarding FUS and TDP-43 activities in 
splicing, the study of mRNA targets of FUS that are shared with TDP-43 are of 
high priority. Recent studies using CLIP technologies have identified a set of 
target mRNAs for TDP-43 and FUS (Tollervey et al., 2011; Polymenidou et al., 
2011; Xiao et al., 2011; Hoell et al., 2011). Several studies suggested that 
HDAC6 might be one of these elusive targets (Fiesel et al., 2010; Kim et al., 
2010). However, in preliminary studies this finding could be not reproduced.  
Thus, the search continues for a specific target of these genes that can be 
validated in animal models.  
A number of studies have identified dysfunction caused by overexpression 
of FUS and TDP-43. In the work in this thesis, no evidence was identified to 
support a gain-of-function model for FUS or TDP-43 in disease. Instead, fALS 
mutants, FUSR522G and FUSP525L showed loss of activity in locomotion and 
longevity experiments. Also, these mutants along with TDP-43M337V showed loss 
of activity NMJ synaptic activity. Once again, overexpression of these proteins 
did not cause observable defects in any of the measures tested.  
The only evidence found in these studies that might support a gain of 
function model of disease is the finding that strong ubiquitous expression of WT 
Caz or TBPH using Daughterless-GAL4 (Da-GAL4) causes complete lethality. It 
is not exactly clear how this experiment informs disease studies since expression 
in neurons and lower level ubiquitous expression is well tolerated. Even still, Da-
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G4 expression of fALS mutant CazR395G partially, but not completely suppresses 
this lethality. Furthermore, studies in mouse models of ALS have begun to unlink 
TDP-43 inclusions as a toxic driving force in disease (Igaz et al., 2011). Using 
expression of varying levels of TDP-43, these authors were able to show that the 
severity of ALS phenotypes correlated more with the absence of TDP-43 from the 
nucleus rather than the presence of inclusions. These findings instead suggest 
that TDP-43 inclusions sequester wild type protein in the cytoplasm leading to a 
loss of its nuclear activity. Similar studies will need to be pursued for FUS.  
In conclusion, the work contained in this thesis provides evidence that ALS 
genes FUS and TDP-43 function in a common molecular pathway in the 
Drosophila nervous system. Biochemical experiments were used to show that 
Caz and TBPH physically interact and that this interaction is dependent on RNA. 
Deletion mutants of the Drosophila homologs of FUS and TDP-43 share common 
phenotypes including defects in adult viability, locomotion, and longevity. In 
addition, overexpression of either gene elicits a gain-of-function synaptic 
overgrowth phenotype. Neuronal replacement of TBPH or TDP-43 fully rescues 
all defects of tbph mutants. Likewise, caz mutants are rescued equally well by 
neuronal expression of either Caz or FUS proteins, although locomotor rescue 
requires additional tissues. tbph mutants are largely improved by expression of 
Caz in cross-rescue experiments. In addition, caz deletion suppresses TBPH 
overexpression phenotypes. In contrast, TBPH modulation was not able to 
modify either gain or loss-of-function of caz. Thus, in Drosophila TDP-43 and 
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FUS function in a common molecular pathway. In this common pathway TDP-43 
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